<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS One</journal-id><journal-id journal-id-type="iso-abbrev">PLoS One</journal-id><journal-id journal-id-type="pmc-domain-id">440</journal-id><journal-id journal-id-type="pmc-domain">plosone</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-title-group><journal-title>PLOS ONE</journal-title></journal-title-group><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>PLOS</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC11695037</article-id><article-id pub-id-type="pmcid-ver">PMC11695037.1</article-id><article-id pub-id-type="pmcaid">11695037</article-id><article-id pub-id-type="pmcaiid">11695037</article-id><article-id pub-id-type="pmid">39746093</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0316262</article-id><article-id pub-id-type="publisher-id">PONE-D-24-12235</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Electrophysiology</subject><subj-group><subject>Membrane Potential</subject><subj-group><subject>Action Potentials</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Electrophysiology</subject><subj-group><subject>Neurophysiology</subject><subj-group><subject>Action Potentials</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Neuroscience</subject><subj-group><subject>Neurophysiology</subject><subj-group><subject>Action Potentials</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Physical Sciences</subject><subj-group><subject>Chemistry</subject><subj-group><subject>Chemical Compounds</subject><subj-group><subject>Alkaloids</subject><subj-group><subject>Muscarine</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Neuroscience</subject><subj-group><subject>Cognitive Science</subject><subj-group><subject>Cognitive Neuroscience</subject><subj-group><subject>Consciousness</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Neuroscience</subject><subj-group><subject>Cognitive Neuroscience</subject><subj-group><subject>Consciousness</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Anesthesiology</subject><subj-group><subject>Anesthesia</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Pharmaceutics</subject><subj-group><subject>Drug Therapy</subject><subj-group><subject>Anesthesia</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Neurochemistry</subject><subj-group><subject>Neurotransmitters</subject><subj-group><subject>Cholinergics</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Neuroscience</subject><subj-group><subject>Neurochemistry</subject><subj-group><subject>Neurotransmitters</subject><subj-group><subject>Cholinergics</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Brain</subject><subj-group><subject>Prefrontal Cortex</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Brain</subject><subj-group><subject>Prefrontal Cortex</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Electrophysiology</subject><subj-group><subject>Membrane Potential</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Cell Biology</subject><subj-group><subject>Cellular Types</subject><subj-group><subject>Animal Cells</subject><subj-group><subject>Neurons</subject><subj-group><subject>Ganglion Cells</subject><subj-group><subject>Pyramidal Cells</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Neuroscience</subject><subj-group><subject>Cellular Neuroscience</subject><subj-group><subject>Neurons</subject><subj-group><subject>Ganglion Cells</subject><subj-group><subject>Pyramidal Cells</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></article-categories><title-group><article-title>Effects of ketamine and propofol on muscarinic plateau potentials in rat neocortical pyramidal cells</article-title><alt-title alt-title-type="running-head">Effects of ketamine and propofol on muscarinic plateau potentials in rat neocortical pyramidal cells</alt-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0009-0008-3867-2431</contrib-id><name name-style="western"><surname>Fleiner</surname><given-names initials="AS">Anne S.</given-names></name><role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role content-type="http://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role content-type="http://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role content-type="http://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role><role content-type="http://credit.niso.org/contributor-roles/project-administration/">Project administration</role><role content-type="http://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#8211; original draft</role><role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#8211; review &amp; editing</role><xref rid="aff001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0009-0004-3196-7051</contrib-id><name name-style="western"><surname>Kolnier</surname><given-names initials="D">Daniel</given-names></name><role content-type="http://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role content-type="http://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role><role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role><role content-type="http://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#8211; original draft</role><role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#8211; review &amp; editing</role><xref rid="aff001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Hagger-Vaughan</surname><given-names initials="N">Nicholas</given-names></name><role content-type="http://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role content-type="http://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role><role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role><role content-type="http://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#8211; original draft</role><role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#8211; review &amp; editing</role><xref rid="aff001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>R&#230;der</surname><given-names initials="J">Johan</given-names></name><role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role><role content-type="http://credit.niso.org/contributor-roles/validation/">Validation</role><xref rid="aff002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Storm</surname><given-names initials="JF">Johan F.</given-names></name><role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role content-type="http://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role content-type="http://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role><role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role><role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role><role content-type="http://credit.niso.org/contributor-roles/project-administration/">Project administration</role><role content-type="http://credit.niso.org/contributor-roles/resources/">Resources</role><role content-type="http://credit.niso.org/contributor-roles/supervision/">Supervision</role><role content-type="http://credit.niso.org/contributor-roles/validation/">Validation</role><role content-type="http://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#8211; original draft</role><role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#8211; review &amp; editing</role><xref rid="aff001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="cor001" ref-type="corresp">*</xref></contrib></contrib-group><aff id="aff001"><label>1</label>
<addr-line>Department of Molecular Medicine, Brain Signalling Laboratory, Institute of Basic Medical Sciences, Section for Physiology, University of Oslo, Oslo, Norway</addr-line></aff><aff id="aff002"><label>2</label>
<addr-line>Institute of Clinical Medicine, University of Oslo, Oslo, Norway</addr-line></aff><contrib-group><contrib contrib-type="editor"><name name-style="western"><surname>Ginsberg</surname><given-names initials="SD">Stephen D.</given-names></name><role>Editor</role><xref rid="edit1" ref-type="aff"/></contrib></contrib-group><aff id="edit1">
<addr-line>Nathan S Kline Institute, UNITED STATES OF AMERICA</addr-line>
</aff><author-notes><fn fn-type="COI-statement" id="coi001"><p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p></fn><corresp id="cor001">* E-mail: <email>j.f.storm@medisin.uio.no</email></corresp></author-notes><pub-date pub-type="epub"><day>2</day><month>1</month><year>2025</year></pub-date><pub-date pub-type="collection"><year>2025</year></pub-date><volume>20</volume><issue>1</issue><issue-id pub-id-type="pmc-issue-id">478219</issue-id><elocation-id>e0316262</elocation-id><history><date date-type="received"><day>10</day><month>6</month><year>2024</year></date><date date-type="accepted"><day>12</day><month>12</month><year>2024</year></date></history><pub-history><event event-type="pmc-release"><date><day>02</day><month>01</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>03</day><month>01</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-01-04 06:25:43.193"><day>04</day><month>01</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>&#169; 2025 Fleiner et al</copyright-statement><copyright-year>2025</copyright-year><copyright-holder>Fleiner et al</copyright-holder><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article distributed under the terms of the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="pone.0316262.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pdf" xlink:href="pone.0316262.pdf"/><abstract><p>Propofol and ketamine are widely used general anaesthetics, but have different effects on consciousness: propofol gives a deeply unconscious state, with little or no dream reports, whereas vivid dreams are often reported after ketamine anaesthesia. Ketamine is an N-methyl-D-aspartate (NMDA) receptor antagonist, while propofol is a &#947;-aminobutyric-acid (GABA<sub>A</sub>) receptor positive allosteric modulator, but these mechanisms do not fully explain how these drugs alter consciousness. Most previous <italic toggle="yes">in vitro</italic> studies of cellular mechanisms of anaesthetics have used brain slices or neurons in a nearly &#8220;comatose&#8221; state, because no &#8220;arousing&#8221; neuromodulators were added. Here we tested mechanisms of anaesthetics in rat medial prefrontal cortex (mPFC) slices after bath-applying the cholinergic agonist muscarine to partly mimic an &#8220;aroused-like&#8221; state, using whole-cell patch-clamp recordings from layer 2/3 pyramidal cells (L2/3PCs). According to leading theories of access consciousness and working memory, L2/3PCs are particularly important for these cognitive functions. We found that muscarine induced long-lasting depolarising plateau potentials (PPs) and spiking following brief depolarising current injections in the L2/3PCs. After 2 hours of pre-incubation with ketamine or propofol, the muscarine-induced PPs were altered in seemingly different ways: 3 &#956;M propofol reduced the PPs and (significantly) spiking, whereas 20 &#956;M ketamine seemed to enhance PPs and spiking (non-significantly). Brief wash-in of these drug concentrations failed to induce such effects, probably due to insufficient equilibration by diffusion in the slices. In contrast, pre-incubation with a high dose (100 &#956;M) of ketamine suppressed the PPs and spiking. We discuss whether the apparently different effects on PPs may possibly be related to contrasting clinical effects: ketamine causing atypical anaesthesia with vivid, &#8220;psychedelic&#8221; dreaming while propofol causes less dreaming.</p></abstract><funding-group><award-group id="award001"><funding-source><institution-wrap><institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100020256</institution-id><institution>Medisinske fakultet, Universitetet i Oslo</institution></institution-wrap></funding-source><award-id>271555/F20</award-id><principal-award-recipient><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0009-0008-3867-2431</contrib-id><name name-style="western"><surname>Fleiner</surname><given-names>Anne S.</given-names></name></principal-award-recipient></award-group><award-group id="award002"><funding-source><institution-wrap><institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100005416</institution-id><institution>Norges Forskningsr&#229;d</institution></institution-wrap></funding-source><award-id>271555/F20</award-id><principal-award-recipient><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0009-0008-3867-2431</contrib-id><name name-style="western"><surname>Fleiner</surname><given-names>Anne S.</given-names></name></principal-award-recipient></award-group><award-group id="award003"><funding-source><institution-wrap><institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100005366</institution-id><institution>Universitetet i Oslo</institution></institution-wrap></funding-source><principal-award-recipient><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0009-0004-3196-7051</contrib-id><name name-style="western"><surname>Kolnier</surname><given-names>Daniel</given-names></name></principal-award-recipient></award-group><award-group id="award004"><funding-source><institution-wrap><institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100018707</institution-id><institution>HORIZON EUROPE Reforming and enhancing the European Research and Innovation system</institution></institution-wrap></funding-source><award-id>945539</award-id><principal-award-recipient><name name-style="western"><surname>Storm</surname><given-names>Johan F.</given-names></name></principal-award-recipient></award-group><award-group id="award005"><funding-source><institution-wrap><institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100005416</institution-id><institution>Norges Forskningsr&#229;d</institution></institution-wrap></funding-source><award-id>NRC grant 262950/F20</award-id><principal-award-recipient><name name-style="western"><surname>Storm</surname><given-names>Johan F.</given-names></name></principal-award-recipient></award-group><funding-statement>This study was supported by a student researcher stipend to ASF from the University of Oslo and The Research Council of Norway (RCN project 271555/F20, The Medical Student Research Program (MSRP), a PhD stipend to DK from the University of Oslo, and by the European Union&#8217;s Horizon 2020 Framework Programme for Research and Innovation under the Specific Grant Agreements No. 785907 and 945539 (Human Brain Project SGA2 and SGA3) to J.F.S., and the Norwegian Research Council (NRC FRIMEDBIO grant 262950/F20) to JFS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement></funding-group><counts><fig-count count="5"/><table-count count="0"/><page-count count="25"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta id="data-availability"><meta-name>Data Availability</meta-name><meta-value>All relevant data are within the manuscript and its <xref rid="sec024" ref-type="sec">Supporting Information</xref> files.</meta-value></custom-meta></custom-meta-group></article-meta><notes><title>Data Availability</title><p>All relevant data are within the manuscript and its <xref rid="sec024" ref-type="sec">Supporting Information</xref> files.</p></notes></front><body><sec sec-type="intro" id="sec001"><title>Introduction</title><p>General anaesthesia (GA) is provided to more than 300 million surgical patients worldwide every year [<xref rid="pone.0316262.ref001" ref-type="bibr">1</xref>], but the neuronal and molecular mechanisms underlying GA-induced unconsciousness are still only partly understood [<xref rid="pone.0316262.ref002" ref-type="bibr">2</xref>&#8211;<xref rid="pone.0316262.ref005" ref-type="bibr">5</xref>]. Propofol and ketamine are widely used for GA, but have quite different effects on consciousness and responsiveness [<xref rid="pone.0316262.ref001" ref-type="bibr">1</xref>,<xref rid="pone.0316262.ref002" ref-type="bibr">2</xref>]. To help elucidate the cellular mechanisms of anaesthetic drugs, we here compare effects of propofol and ketamine in cortical brain slices from rats.</p><p>In consciousness research, the term &#8220;unconsciousness&#8221; is used for states lacking all forms of subjective experience, including &#8220;inner&#8221; experiences like dreaming or hallucinations [<xref rid="pone.0316262.ref006" ref-type="bibr">6</xref>]. In contrast, in anaesthesiology and other clinical disciplines, &#8220;unconsciousness&#8221; is often used for a state characterised by lack of overt responses to or recall of pain and other stimuli&#8211;a state called &#8220;unresponsiveness&#8221; in consciousness science [<xref rid="pone.0316262.ref006" ref-type="bibr">6</xref>]. Recognising this conceptual distinction, and the evidence for dreaming during GA [<xref rid="pone.0316262.ref007" ref-type="bibr">7</xref>&#8211;<xref rid="pone.0316262.ref009" ref-type="bibr">9</xref>], we here use the term &#8220;unresponsiveness&#8221; rather than &#8220;unconsciousness&#8221; for the state induced by GA.</p><p>To study synaptic, cellular, and molecular effects and mechanisms of anaesthetics in mammals, <italic toggle="yes">in vitro</italic> brain slices and cultured neurons have often been used [<xref rid="pone.0316262.ref010" ref-type="bibr">10</xref>&#8211;<xref rid="pone.0316262.ref016" ref-type="bibr">16</xref>]. However, depriving the cerebral cortex of arousing neuromodulatory input from the ascending reticular activation system (ARAS) [<xref rid="pone.0316262.ref017" ref-type="bibr">17</xref>,<xref rid="pone.0316262.ref018" ref-type="bibr">18</xref>], basal forebrain, and thalamus, e.g. by cutting ARAS axons, causes coma <italic toggle="yes">in vivo</italic> [<xref rid="pone.0316262.ref019" ref-type="bibr">19</xref>,<xref rid="pone.0316262.ref020" ref-type="bibr">20</xref>]. Since isolated cortical slices have lost such neuromodulatory input, the physiological state of the sliced tissue probably corresponds more closely to a &#8220;comatose&#8221; state than the normal, awake, conscious state <italic toggle="yes">in vivo</italic>, unless the lost neuromodulatory input is somehow substituted [<xref rid="pone.0316262.ref020" ref-type="bibr">20</xref>,<xref rid="pone.0316262.ref021" ref-type="bibr">21</xref>]. Therefore, in this study, we decided to test mechanisms of anaesthetics <italic toggle="yes">in vitro</italic> after first trying to induce (mimic) a partly &#8220;aroused-&#8221; or&#8221;awake-like&#8221; physiological state in the cortical tissue (here dubbed &#8220;<italic toggle="yes">The arousal first approach</italic>&#8221;; see below), by bath-applying a cholinergic agonist.</p><p>In previous studies, cholinergic agonists, alone or in combination with other drugs, have been used to induce [<xref rid="pone.0316262.ref022" ref-type="bibr">22</xref>&#8211;<xref rid="pone.0316262.ref024" ref-type="bibr">24</xref>] or modulate [<xref rid="pone.0316262.ref021" ref-type="bibr">21</xref>] <italic toggle="yes">in vivo</italic>-like network oscillations or bistability <italic toggle="yes">in vitro</italic>. The cholinergic agonist carbachol evoked network oscillations in the theta [<xref rid="pone.0316262.ref024" ref-type="bibr">24</xref>] and gamma frequency ranges [<xref rid="pone.0316262.ref022" ref-type="bibr">22</xref>,<xref rid="pone.0316262.ref023" ref-type="bibr">23</xref>] in hippocampal slices, showing that such synchronised activity can arise without rhythmic inputs. Using a GABA<sub>A</sub>-receptor blocker to mimic disinhibition, combined with carbachol to obtain &#8220;pharmacological conditions that mimicked endogenous ascending cholinergic and GABAergic inputs&#8221;, Lukatch et al. (2005) [<xref rid="pone.0316262.ref025" ref-type="bibr">25</xref>] showed that intrinsic neocortical circuitry can generate <italic toggle="yes">in vivo</italic>-like theta oscillations, and provided &#8220;evidence for cholinergic-GABAergic interaction&#8221; [<xref rid="pone.0316262.ref026" ref-type="bibr">26</xref>]. Propofol abolished the carbachol-induced theta oscillations and induced a burst suppression-like pattern, reminiscent of those observed clinically during propofol anaesthesia [<xref rid="pone.0316262.ref025" ref-type="bibr">25</xref>]. Propofol has also been shown to inhibit gamma oscillations in hippocampal slices [<xref rid="pone.0316262.ref027" ref-type="bibr">27</xref>], whereas ketamine did not suppress such oscillations [<xref rid="pone.0316262.ref028" ref-type="bibr">28</xref>,<xref rid="pone.0316262.ref029" ref-type="bibr">29</xref>]. However, several studies (1998&#8211;2019) have investigated effects and mechanisms of anaesthetics <italic toggle="yes">in vitro</italic> without applying cholinergic or other ARAS-related agonists [<xref rid="pone.0316262.ref010" ref-type="bibr">10</xref>&#8211;<xref rid="pone.0316262.ref016" ref-type="bibr">16</xref>].</p><p>In the present study, we chose to use only muscarine for inducing a partially &#8220;arousal-like&#8221; state in the cortical slices, because the muscarinic effects of acetylcholine (ACh) on cortical pyramidal cells are particularly powerful [<xref rid="pone.0316262.ref030" ref-type="bibr">30</xref>&#8211;<xref rid="pone.0316262.ref032" ref-type="bibr">32</xref>], and can be induced in an easily controllable manner. An additional reason for this choice, is our recent finding [<xref rid="pone.0316262.ref033" ref-type="bibr">33</xref>] that muscarine alone induces plateau potentials in layer 2 and 3 pyramidal cells (L2/3PCs) in rat medial prefrontal cortex (mPFC)&#8212;a mechanism that profoundly alters the input-output function of this class of neurons, which may be particularly important for access consciousness according to leading theories [<xref rid="pone.0316262.ref034" ref-type="bibr">34</xref>]. These factors may thus be important for transitions between conscious and unconscious states, and hence possibly for anaesthetics.</p><p>Another problem with many <italic toggle="yes">in vitro</italic> studies of anaesthetics is the difficulty of relating clinically relevant concentrations and effects of anaesthetic drugs in humans during general anaesthesia, to drug levels used and effects observed in isolated brain slices lacking blood supply. We get back to these complex issues in the Discussion and Supplement 1. In this study, we used concentrations of ketamine (20 &#956;M) and propofol (3 &#956;M) that seem likely to approach (albeit higher than) the estimated clinically relevant free concentrations of these drugs in the human brain, but lower than concentrations often used in previous brain slice studies. In addition, we tested higher concentrations for comparison (100 &#956;M ketamine; and 10 &#956;M propofol).</p><p>Propofol and ketamine have quite different effects on consciousness (in the sense of this term that also includes inner experiences). At surgical GA doses, propofol gives an unconscious state, with little or no dream reports after awakening [<xref rid="pone.0316262.ref035" ref-type="bibr">35</xref>,<xref rid="pone.0316262.ref036" ref-type="bibr">36</xref>]. In contrast, rich and vivid dreams, often intense and with &#8220;psychedelic&#8221; content, are frequently reported after surgical ketamine anaesthesia [<xref rid="pone.0316262.ref007" ref-type="bibr">7</xref>,<xref rid="pone.0316262.ref008" ref-type="bibr">8</xref>].</p><p>The cellular and molecular mechanisms underlying clinical GA with ketamine and propofol are also known to be very different [<xref rid="pone.0316262.ref002" ref-type="bibr">2</xref>], but still remain to be fully elucidated. Furthermore, the connections between the mechanisms of these two anaesthetics and their different effects on consciousness (reported subjective experience) remain to be fully understood [<xref rid="pone.0316262.ref002" ref-type="bibr">2</xref>].</p><p>Like most general anaesthetics, propofol potentiates GABA<sub>A</sub> receptors [<xref rid="pone.0316262.ref037" ref-type="bibr">37</xref>,<xref rid="pone.0316262.ref038" ref-type="bibr">38</xref>] (positive allosteric modulator) leading to enhanced inhibition, which is supposed to cause sedation and loss of consciousness [<xref rid="pone.0316262.ref002" ref-type="bibr">2</xref>]. In contrast, the anaesthetic effect of ketamine is mainly ascribed to its noncompetitive N-methyl-D-aspartate (NMDA) receptor antagonism, causing reduced excitatory neurotransmission and unresponsiveness [<xref rid="pone.0316262.ref002" ref-type="bibr">2</xref>]. Another possibility is that ketamine, acting on different NMDAR subtypes, partly blocks NMDARs that stimulate inhibitory GABAergic interneurons, thus causing disinhibition and increased network activity [<xref rid="pone.0316262.ref039" ref-type="bibr">39</xref>]. However, these different mechanisms do not seem to entirely explain how these drugs alter consciousness and responsiveness.</p><p>Propofol is currently the most common anaesthetic used to induce and maintain surgical anaesthesia [<xref rid="pone.0316262.ref040" ref-type="bibr">40</xref>]. In addition to its potentiation of GABA<sub>A</sub> receptors, propofol has also been found to affect several other molecular targets; e.g. it inhibits hyperpolarisation-activated cyclic nucleotide&#8211;gated (HCN) channels [<xref rid="pone.0316262.ref041" ref-type="bibr">41</xref>], calcium-activated potassium channels [<xref rid="pone.0316262.ref042" ref-type="bibr">42</xref>], L-type voltage-gated calcium channels [<xref rid="pone.0316262.ref043" ref-type="bibr">43</xref>], and transient receptor potential (TRP) channels [<xref rid="pone.0316262.ref044" ref-type="bibr">44</xref>].</p><p>Ketamine is most commonly used for anaesthesia in hypovolemic patients and trauma surgery due to its favourable cardiovascular effects in such patients [<xref rid="pone.0316262.ref045" ref-type="bibr">45</xref>]. More widespread use of ketamine is restricted mostly due to the risk of unpleasant, nightmare-like awakenings [<xref rid="pone.0316262.ref046" ref-type="bibr">46</xref>]. Similarly to propofol, a wide range of other molecular targets for ketamine have been found (in addition to NMDA receptors), which could also contribute to the anaesthetic effect, including inhibition of acetylcholine release [<xref rid="pone.0316262.ref047" ref-type="bibr">47</xref>], HCN channels [<xref rid="pone.0316262.ref048" ref-type="bibr">48</xref>], and L-type calcium channels [<xref rid="pone.0316262.ref049" ref-type="bibr">49</xref>], and enhancement of BDNF signalling [<xref rid="pone.0316262.ref050" ref-type="bibr">50</xref>].</p><p>Studies using transcranial magnetic stimulation (TMS) combined with EEG to assess consciousness in humans (the perturbational complexity index, PCI, method; [<xref rid="pone.0316262.ref051" ref-type="bibr">51</xref>] found that the brain (cortex) is in a so-called &#8220;low-complexity state&#8221; during propofol anaesthesia [<xref rid="pone.0316262.ref009" ref-type="bibr">9</xref>] with an EEG pattern modestly resembling that of sleep [<xref rid="pone.0316262.ref052" ref-type="bibr">52</xref>], with few or no post-anaesthesia reports of dreaming [<xref rid="pone.0316262.ref009" ref-type="bibr">9</xref>]. In contrast, ketamine anaesthesia leads to a state of unresponsiveness with a high-complexity brain state [<xref rid="pone.0316262.ref009" ref-type="bibr">9</xref>] with EEG patterns resembling those of wakefulness [<xref rid="pone.0316262.ref053" ref-type="bibr">53</xref>], and is often followed by recollections of vivid dreams experienced during anaesthesia [<xref rid="pone.0316262.ref007" ref-type="bibr">7</xref>,<xref rid="pone.0316262.ref008" ref-type="bibr">8</xref>].</p><p>Since reports of dreams or other conscious experiences are much less common following propofol compared to ketamine anaesthesia [<xref rid="pone.0316262.ref035" ref-type="bibr">35</xref>], this has led to the interpretation that whilst both drugs cause unresponsiveness to pain and other stimuli (i.e., surgical anaesthesia), a form of consciousness is retained during ketamine, leading to internal experience without responsiveness, similar to that during REM sleep [<xref rid="pone.0316262.ref054" ref-type="bibr">54</xref>,<xref rid="pone.0316262.ref055" ref-type="bibr">55</xref>]. To help elucidate the causes of these differences, it is important to further investigate the cellular effects of ketamine in comparison with more typical anaesthetics such as propofol.</p><p>The &#8220;seat&#8221; of consciousness in the brain is a highly contested topic [<xref rid="pone.0316262.ref056" ref-type="bibr">56</xref>]. The prefrontal cortex (PFC) is implicated as a key area in several leading theories including the global neuronal workspace theory (GNWT) [<xref rid="pone.0316262.ref034" ref-type="bibr">34</xref>] and higher-order thought (HoT) theories [<xref rid="pone.0316262.ref057" ref-type="bibr">57</xref>], as well as in functions related to consciousness such as attention [<xref rid="pone.0316262.ref058" ref-type="bibr">58</xref>,<xref rid="pone.0316262.ref059" ref-type="bibr">59</xref>], working memory [<xref rid="pone.0316262.ref060" ref-type="bibr">60</xref>], and emotional processing [<xref rid="pone.0316262.ref061" ref-type="bibr">61</xref>]. Therefore, this area is of great interest for the study of effects of anaesthetics on individual neurons.</p><p>Within the PFC, layer 2/3 pyramidal cells (L2/3PCs) are particularly relevant for the &#8220;frontal&#8221; theories of consciousness (GNWT; HOT) due to their long-range axonal projections, which make extensive corticocortical and subcortical connections that support the recurrent processing required by these theories [<xref rid="pone.0316262.ref062" ref-type="bibr">62</xref>]. Thus, the L2/3PCs with their long axons are supposed to form the main basis for the &#8220;global workspace&#8221; of the GNWT [<xref rid="pone.0316262.ref034" ref-type="bibr">34</xref>,<xref rid="pone.0316262.ref063" ref-type="bibr">63</xref>,<xref rid="pone.0316262.ref064" ref-type="bibr">64</xref>].</p><p>The ability to switch to conscious states is mainly caused by long ascending projections from the reticular activation system (ARAS) and basal forebrain nuclei, which provide neuromodulatory input to the cortex, including ACh and monoamine neurotransmitters [<xref rid="pone.0316262.ref065" ref-type="bibr">65</xref>]. The combined effect of neuromodulator release following ARAS activation is a transition from sleep to wakefulness [<xref rid="pone.0316262.ref066" ref-type="bibr">66</xref>], and wakefulness and conscious states are associated with high cortical levels of acetylcholine and monoamines [<xref rid="pone.0316262.ref067" ref-type="bibr">67</xref>,<xref rid="pone.0316262.ref068" ref-type="bibr">68</xref>]. When the modulatory input from the ARAS and basal forebrain is severely reduced, for example by brain stem lesions, with consequent loss of its long-range cholinergic and monoaminergic projections to the cortex and forebrain, the individual enters a comatose state, with loss of consciousness and normal, awake activity [<xref rid="pone.0316262.ref069" ref-type="bibr">69</xref>]. Therefore, the effects of these neuromodulators on neuronal and synaptic physiology are of great interest.</p><p>ACh and other cholinergic agonists can induce broad, lasting changes in neuronal physiology via the signalling cascades induced by activation of muscarinic ACh receptors (mAChRs). Muscarinic effects include drastic alterations of spike frequency adaptation, which is a key parameter for transition to the aroused state [<xref rid="pone.0316262.ref021" ref-type="bibr">21</xref>,<xref rid="pone.0316262.ref070" ref-type="bibr">70</xref>,<xref rid="pone.0316262.ref071" ref-type="bibr">71</xref>]. Cholinergic agonists like ACh can also induce powerful slow afterdepolarisations or plateau potentials (PPs) [<xref rid="pone.0316262.ref032" ref-type="bibr">32</xref>,<xref rid="pone.0316262.ref072" ref-type="bibr">72</xref>&#8211;<xref rid="pone.0316262.ref079" ref-type="bibr">79</xref>], i.e., extended periods of depolarisation and action potential firing which often greatly outlast the initial depolarising stimulus, and fundamentally alters the input-output functions of these neurons in the awake state compared to unconscious states.</p><p>PPs have been implicated in the induction of long-term potentiation [<xref rid="pone.0316262.ref080" ref-type="bibr">80</xref>], a likely mechanism of long-term memory [<xref rid="pone.0316262.ref081" ref-type="bibr">81</xref>], and working memory [<xref rid="pone.0316262.ref073" ref-type="bibr">73</xref>], by keeping information present in a network beyond the termination of a sensory stimulus [<xref rid="pone.0316262.ref034" ref-type="bibr">34</xref>]. PPs have been suggested to be fundamentally involved in consciousness by acting as a mechanism of detecting coincident sensory and contextual input and amplifying action potential output, allowing that information to enter conscious awareness [<xref rid="pone.0316262.ref082" ref-type="bibr">82</xref>]. PPs have been observed in a range of different neuron types and brain areas [<xref rid="pone.0316262.ref072" ref-type="bibr">72</xref>,<xref rid="pone.0316262.ref083" ref-type="bibr">83</xref>&#8211;<xref rid="pone.0316262.ref085" ref-type="bibr">85</xref>]. Recently we found that muscarine alone induces PPs in PFC L2/3PCs following depolarising current injections, and characterised the molecular and morphological underpinnings of these PPs [<xref rid="pone.0316262.ref033" ref-type="bibr">33</xref>].</p><p>As PPs may be a key mechanism for supporting consciousness, their sensitivity to anaesthetics is of interest, in particular whether the effects of ketamine and propofol on PPs differ, which might help explain their very different effects on brain state and consciousness.</p><p>In this <italic toggle="yes">in vitro</italic> patch clamp study we investigate and compare the effects of brief and extended exposure to a range of relevant concentrations of ketamine or propofol on muscarinic PPs in L2/3PCs in the PFC. We find that brief exposure to high concentrations of ketamine (100 &#956;M) or propofol (10 &#956;M), and long incubation with lower concentrations of propofol (3 &#956;M) caused a significantly reduced incidence (and reduced amplitude for 100 &#956;M ketamine) of PPs, with less associated spiking. Lower concentrations of ketamine did not result in such effects. We discuss whether and how these cellular effects may contribute to the different anaesthetic effects of ketamine and propofol.</p></sec><sec sec-type="materials|methods" id="sec002"><title>Materials and methods</title><sec id="sec003"><title>Ethical approval</title><p>All animal procedures were approved by the responsible veterinarian of the institute, in accordance with the statute regulating animal experimentation (Norwegian Ministry of Agriculture, 1996).</p></sec><sec id="sec004"><title>mPFC slice preparation, maintenance, and perfusion of recording chamber</title><p>Coronal prefrontal slices were obtained from young (P21-P28), male Wistar rats (Scanbur AS, Nittedal, Norway). Rats were anaesthetised with isoflurane inhalation and decapitated. The brain was removed quickly into ice-cold sucrose-based artificial cerebrospinal fluid (aCSF) containing (in mM): 87 NaCl, 1.25 KCl, 1.25 KH<sub>2</sub>PO<sub>4</sub>, 7 MgCl<sub>2</sub>, 0.5 CaCl<sub>2</sub>, 16 glucose, 75 sucrose, 25 NaHCO<sub>3</sub>, saturated with 95% O<sub>2</sub>&#8722;5% CO<sub>2</sub>. 400 &#956;m thick slices were cut using a Leica VT1200 vibratome (Leica Microsystems; Wetzlar, Germany) and incubated for 30 min at 35&#176;C in aCSF containing (in mM): 125 NaCl, 2.5 KCl, 1.25 NaH<sub>2</sub>PO<sub>4</sub>, 1.4 MgCl<sub>2</sub>, 1.6 CaCl<sub>2</sub>, 16 glucose, 25 NaHCO<sub>3</sub>, saturated with 95% O<sub>2</sub>&#8722;5% CO<sub>2</sub>. After incubation, slices were kept at room temperature (~20&#176;C) until use.</p><p>For propofol experiments, PTFE tubing was used for delivering aCSF to the slice chamber to avoid absorption of propofol into silicone or Tygon tubing, as has previously been reported [<xref rid="pone.0316262.ref086" ref-type="bibr">86</xref>]. Propofol was freshly diluted on the day of the experiments. For experiments using slices that were pre-incubated with either ketamine or propofol, we used glass holding chambers for the pre-incubation to avoid absorption of any drugs, thereby diminishing the effective concentration in the medium. These slices were incubated in ketamine or propofol for at least two hours before performing recordings, to allow the drugs to equilibrate in the tissue. It was previously shown that 2 hours incubation is sufficient to reach concentrations close to equilibrium for propofol near the surface of the slices, at depths down to ~50 &#956;m, where all our somatic whole-cell recordings were obtained, and 2 hours far exceeded the time taken to reach equilibrium for ketamine [<xref rid="pone.0316262.ref087" ref-type="bibr">87</xref>,<xref rid="pone.0316262.ref088" ref-type="bibr">88</xref>]. Control cells in these experiments were from slices incubated for the same duration in standard aCSF, to compensate for any potential time-dependent effects of the incubation per se. In some experiments, the synaptic blockers SR 95531 (gabazine; 5 &#956;M), DNQX (10 &#956;M), and APV (50 &#956;M) were included in the aCSF to block glutamatergic and GABA<sub>A</sub>-ergic transmission. No differences in the amplitude, duration, or induced spiking of plateau potentials were observed between experiments with or without synaptic blockers, therefore data from both conditions have been merged for the subsequent analysis.</p></sec><sec id="sec005"><title>Electrophysiology</title><p>Whole-cell current-clamp recordings were obtained using visual guidance from IR-DIC optics (BX51WI; Olympus, Tokyo, Japan) from the somata of L2/3 mPFC pyramidal cells. Slices were maintained at 32 &#177; 1&#176;C and superfused with aCSF. Patch-clamp pipettes (5&#8211;7 M&#937;) were pulled from borosilicate glass tubing (outer diameter 1.5 mm, inner diameter 0.86 mm, with filament; Sutter Instruments, Novato, CA, USA) and filled with a solution containing (in mM): 120 K-methanesulfonate, 4 Na<sub>2</sub>ATP, 0.3 NaGTP, 10 Na<sub>2</sub>phosphocreatine, 10 KCl, 3 MgCl<sub>2</sub>, 10 inositol, 10 HEPES. The pH of the intracellular medium was adjusted to 7.2&#8211;7.3 with KOH, and osmolarity was between 290 and 300 mOsmol<sup>&#8722;1</sup>. Recordings were made using either a Dagan BVC-700A patch-clamp amplifier (Dagan Corporation, Minneapolis, MN, USA) or a Multiclamp 700A (Molecular Devices, San Jose, CA, USA), low-pass filtered at 10 kHz, and digitised at 20 kHz. Access resistance was typically between 10 and 30 M&#937; and was compensated at the beginning of every recording and adjusted as required.</p></sec><sec id="sec006"><title>Stimulation protocol</title><p>Injecting trains of short (2 ms), depolarising current pulses (1.0&#8211;1.5 nA; amplitude adjusted to elicit only a single spike per pulse), we repeatedly induced trains of 7 action potentials at 70 Hz, once every 5 minutes.</p></sec><sec id="sec007"><title>Data acquisition and analysis</title><p>Data were acquired using pCLAMP 10 software and digitised with either a Digidata 1322A or Digidata 1440 (Molecular Devices). The analysis was carried out using Clampfit software (Molecular Devices), and results were plotted and statistical analysis performed in Origin 2020 (OriginLab Corp; Northampton, MA, USA) and GraphPad Prism, version 9. Cells were manually held at a baseline membrane potential of -60 mV by DC current injections. Recordings were made in current-clamp after obtaining a seal of 1 G&#937; or tighter. The potentials reported here were not corrected for the junction potential, which was calculated to be 9.4 mV between the intracellular solution and the aCSF used here. The plateau potential was quantified using two different parameters: the post-burst area and post-burst spikes. The post-burst area was defined as the area under the curve (either positive-going or negative-going) in the first 10 seconds following the initial elicited spike burst (<bold><xref rid="pone.0316262.g001" ref-type="fig">Fig 1B</xref></bold>; area indicated by grey shading). Post-burst spikes were defined as the number of spikes observed in the first 10 seconds following the initial elicited spike burst (<bold><xref rid="pone.0316262.g001" ref-type="fig">Fig 1B</xref></bold> lower trace and inset). In wash-in experiments, we excluded all cells that did not elicit spiking plateau potentials after the wash-in of muscarine to increase the probability that we were testing a quite uniform subpopulation of cells.</p><fig position="float" id="pone.0316262.g001" orientation="portrait"><object-id pub-id-type="doi">10.1371/journal.pone.0316262.g001</object-id><label>Fig 1</label><caption><title>Experimental details and analysis of muscarine-induced plateau potentials.</title><p>A) Example traces of the membrane potential following 7 action potentials at 70 Hz elicited by the injection of 7 brief, depolarising current pulses (lower trace) in control conditions (top) and following bath application of 10 &#956;M muscarine (middle). B) Typical examples of traces before (top) and after muscarine application (bottom) to show how plateau potentials (PPs) were measured. The area of the after-potentials, i.e., the membrane potential deviation after the 7th spike (the deviation from the mean membrane potential before the 1st spike) is marked by grey shading. In the absence of muscarine (Control; upper trace; enhanced scale inset), there was an afterhyperpolarisation (AHP) after the spikes, whereas the muscarine-treated cells showed a long-lasting afterdepolarisation, called a &#8220;plateau potential&#8221; (PP, lower trace). The number of action potentials following the initial burst is referred to as &#8217;spikes&#8217; and is illustrated in the inset of the lower trace. The area measurements and spike counts started immediately after the spikes elicited by current injections. The red, dotted lines on the far-right of the traces denote the endpoints of the measurements and spike counts. C) Summary chart showing the proportion of cells (%) exhibiting a spiking plateau following the application of muscarine. Only cells from slices incubated (30 min) in control aCSF (no ketamine or propofol) are included. Raw cell count is shown adjacent to each sector.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="pone.0316262.g001.jpg"/></fig><p>Data are reported as the mean &#177; standard error of the mean (SEM). Non-parametric tests were used to compare groups as group sizes tended to be too small to determine whether they were normally distributed. Statistical comparisons were made using Mann-Whitney U test (MWU). Normalising of data was performed by dividing the value at each time point in the individual trials by the area or number of spikes after the wash-in of muscarine (time = 5 minutes). We normalised the data from wash-in experiments (<bold>Figs <xref rid="pone.0316262.g002" ref-type="fig">2</xref></bold> and <bold><xref rid="pone.0316262.g004" ref-type="fig">4</xref></bold>) to investigate the relative change in area and spiking after the wash-in of propofol and ketamine. The data from the pre-incubation experiments (<bold>Figs <xref rid="pone.0316262.g003" ref-type="fig">3</xref></bold> and <bold><xref rid="pone.0316262.g005" ref-type="fig">5</xref></bold>) was not normalised, as the absolute area and spiking value are of interest.</p><fig position="float" id="pone.0316262.g002" orientation="portrait"><object-id pub-id-type="doi">10.1371/journal.pone.0316262.g002</object-id><label>Fig 2</label><caption><title>Ketamine wash-in.</title><p>A) Example traces, among the closest to the mean, showing the effect on the muscarinic plateau after a 5-minute wash-in of ketamine (20 &#956;M (ii) or 100 &#956;M (iii) compared to the time-matched control, where the whole-cell recordings were maintained for the same period of time (5 min), but without adding any ketamine (0 &#956;M (i), ketamine). B) Time course plots showing the normalised area (i) and spikes (ii) following the wash-in of muscarine and then the subsequent wash-in, then wash-out of ketamine at different concentrations (0 &#956;M: n = 6; 20 &#956;M: n = 16; 100 &#956;M; n = 7; Error bars = SEM). We plotted normalised values here, to visualise the ketamine effects relative to the different plateau sizes and spike counts before adding ketamine (see black traces in Ai-Aiii). C) Summary plots of the change in area (i) and spikes (ii) following application of ketamine at different concentrations, relative to prior to the wash-in of ketamine in the presence of muscarine. (i) The change in the post-burst area was not significantly different at any of the tested ketamine concentrations (MWU test, 0 &#956;M; n = 6, 20 &#956;M; n = 16, 100 &#956;M; n = 7). (ii) The change in post-burst spiking after the wash-in of 20 &#956;M and 100 &#956;M was not significant compared to the control (MWU test). However, the decrease in post-burst spiking was significantly larger after the wash-in of 100 &#956;M ketamine than with 20 &#956;M (MWU test). Error bars = 95% CI. * = p&lt;0.05, ns = p&gt;0.05.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="pone.0316262.g002.jpg"/></fig><fig position="float" id="pone.0316262.g003" orientation="portrait"><object-id pub-id-type="doi">10.1371/journal.pone.0316262.g003</object-id><label>Fig 3</label><caption><title>Ketamine pre-incubation.</title><p>A) Example traces showing plateau potentials induced by wash-in of 10 &#956;M muscarine, following long-lasting (2 hour) pre-incubation either without ketamine (0 &#956;M) (i), or with 20 &#956;M (ii), or 100 &#956;M (iii) ketamine.B) Summary chart showing the number of cells exhibiting a spiking plateau or no spiking plateau, following incubation in control aCSF, 20 &#956;M, and 100 &#956;M ketamine. C) Time course plots showing the area (i) and spikes (ii) following the wash-in of muscarine in the presence of ketamine at different concentrations. Error bars = SEM. D) Summary plots of the area (i) and spikes (ii) following incubation in ketamine at different concentrations, measured at the first elicited spike burst after the wash-in of muscarine (time = 5 minutes). (i) No significant difference in post-burst area between the control (0 &#956;M) and 20 &#956;M ketamine was observed. The post-burst area was significantly smaller after wash-in of muscarine in slices incubated in 100 &#956;M ketamine than in 0 &#956;M and 20 &#956;M (MWU test; 0 &#956;M: n = 12; 20 &#956;M: n = 10; 100 &#956;M: n = 12). (ii) No significant difference in spiking was observed between slices incubated in 0 &#956;M and 20 &#956;M ketamine, but there was a significant difference between 0 &#956;M and 100 &#956;M, and 20 &#956;M and 100 &#956;M ketamine (MWU test; 0 &#956;M: n = 12; 20 &#956;M: n = 10; 100 &#956;M: n = 12). Error bars = 95% CI. * = p&lt;0.05, ns = p&gt;0.05.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="pone.0316262.g003.jpg"/></fig></sec><sec id="sec008"><title>Chemicals</title><p>Muscarine and SR-95531 (gabazine) were obtained from Tocris Bioscience (Bristol, UK), racemic ketamine 50 mg/ml from Abcur AB (Helsingborg, Sweden), propofol 10 mg/ml from Sigma-Aldrich Norway AS (Oslo, Norway), DNQX and APV from Alemone (Jerusalem, Israel). Potassium gluconate, KMeSO3, and the other substances used for preparing the solutions were obtained from Sigma-Aldrich Norway AS (Oslo, Norway). All chemicals tested in the experiments were bath applied at a superfusion rate of ~3 ml/min. The synaptic blockers APV, gabazine and DNQX were included in the aCSF prior to the start of the experiment in 92 out of 177 cells (52%). We observed no notable difference, neither in intrinsic neuronal properties nor in the size and spiking of the muscarine-induced plateau potentials, between the cells with and without synaptic blockers. The reasons for choosing the concentrations of ketamine and propofol that we used are discussed in the Introduction and Discussion.</p></sec></sec><sec sec-type="results" id="sec009"><title>Results</title><sec id="sec010"><title>Muscarinic plateaus in the mPFC</title><p>We obtained stable somatic whole-cell recordings from L2/3 pyramidal cells (n = 177) in brain slices from the medial prefrontal cortex (mPFC). Of these 177 cells, 127 were recorded after regular incubation in control aCSF (no propofol or ketamine; <bold>Figs <xref rid="pone.0316262.g001" ref-type="fig">1</xref></bold>, <bold><xref rid="pone.0316262.g002" ref-type="fig">2</xref></bold>, <bold><xref rid="pone.0316262.g004" ref-type="fig">4</xref></bold> and <bold><xref rid="pone.0316262.s001" ref-type="supplementary-material">S1</xref></bold>), whereas 50 cells were cells recorded after prolonged pre-incubation with or without an anaesthetic drug (for 2 hours or more in either control aCSF, or with propofol, or ketamine; <bold>Figs <xref rid="pone.0316262.g003" ref-type="fig">3</xref></bold> and <bold><xref rid="pone.0316262.g005" ref-type="fig">5</xref></bold>). A mean resting potential of -70.6&#177;0.66 mV was observed under control conditions in these cells (n = 40), with an input resistance of 96.3 &#177;5.25 M&#937; (n = 32). No spontaneous spiking was observed before or after adding muscarine in any of the cells under the conditions used here. Cells were manually held at a membrane potential of -60 mV by a positive holding current of 146&#177;12.4 pA (n = 45).</p><fig position="float" id="pone.0316262.g004" orientation="portrait"><object-id pub-id-type="doi">10.1371/journal.pone.0316262.g004</object-id><label>Fig 4</label><caption><title>Propofol wash-in.</title><p>A) Example traces of the muscarinic plateau before and after 5 minutes of wash-in of propofol 0 &#956;M (i), 3 &#956;M (ii) or 10 &#956;M (iii). B) Time course plots showing the normalised area (i) and spikes (ii) following the application of propofol. Data are normalised to values observed following muscarine application, before application of propofol. Error bars = SEM. We plotted normalised values here, to visualise the propofol effects relative to the different plateau sizes and spike counts before adding propofol (see black traces in Ai-Aiii). C) Summary plots of the change in area (i) and spikes (ii) following application of propofol at different concentrations relative to prior to the wash-in of propofol. (i) There was no difference in the change in the post-burst area between any of the concentrations of propofol used following 5 minutes of wash-in (MWU test; 0 &#956;M: n = 10; 3 &#956;M: n = 8; 10 &#956;M: n = 10). (ii) A significantly larger decrease in post-burst spikes was observed after wash-in of both 3 &#956;M and 10 &#956;M propofol compared to the control (0 &#956;M). The decrease in spiking after wash-in of 3 &#956;M and 10 &#956;M was not significantly different (MWU test; 0 &#956;M: n = 10; 3 &#956;M: n = 8; 10 &#956;M: n = 10). Error bars = 95% CI. * = p&lt;0.05, ns = p&gt;0.05.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="pone.0316262.g004.jpg"/></fig><fig position="float" id="pone.0316262.g005" orientation="portrait"><object-id pub-id-type="doi">10.1371/journal.pone.0316262.g005</object-id><label>Fig 5</label><caption><title>Propofol pre-incubation.</title><p>A) Example traces of the muscarinic plateau potentials induced by wash-in of 10 &#956;M muscarine, following long-lasting (2 hour) pre-incubation either without propofol (0 &#956;M) (i) or with 3 &#956;M (ii) propofol. B) Summary chart showing the proportion of cells exhibiting a spiking plateau or no spiking plateau, following incubation in control aCSF or 3 &#956;M propofol. C) Time course plots showing the area (i) and spikes (ii) following the application of muscarine after slice incubation in propofol. Error bars = SEM. D) Summary plots of the change in area (i) and spikes (ii) following incubation in control aCSF or 3 &#956;M propofol, measured at the first elicited spike burst after the wash-in of muscarine (time = 5 minutes). (i) Wash-in of muscarine after incubation in 3 &#956;M propofol had no significantly different effect on post-burst area from incubation in 0 &#956;M propofol (MWU test; 0 &#956;M: n = 12; 3 &#956;M: n = 16). (ii) There were significantly fewer post-burst spikes after wash-in of muscarine in slices incubated in 3 &#956;M than in control incubation (MWU test; 0 &#956;M: n = 12; 3 &#956;M: n = 16). Error bars = 95% CI. * = p&lt;0.05, ns = p&gt;0.05.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="pone.0316262.g005.jpg"/></fig><p>By injecting trains of short (2 ms), depolarising current pulses (1.0&#8211;1.5 nA; amplitude adjusted to elicit only a single spike per pulse), we repeatedly induced trains of 7 action potentials at 70 Hz, once every 5 minutes. After bath application of muscarine (10 &#956;M; <bold><xref rid="pone.0316262.g001" ref-type="fig">Fig 1A</xref></bold>), each spike train was followed by a plateau potential (PP), as described previously [<xref rid="pone.0316262.ref033" ref-type="bibr">33</xref>]. The PPs and spiking were quantified by measuring (1) the area under the PP curve (area; <bold><xref rid="pone.0316262.g001" ref-type="fig">Fig 1B</xref></bold> upper trace), and (2) the number of PP-triggered action potentials (spike number; <bold><xref rid="pone.0316262.g001" ref-type="fig">Fig 1B</xref></bold> lower trace) following the elicited burst of 7 spikes. The area was calculated as the integral of the membrane potential deviation from the baseline holding membrane potential in the 10 seconds following the offset of the current pulse train.</p><p>We have previously found that this concentration of muscarine most reliably induced plateau potentials in this cell type [<xref rid="pone.0316262.ref033" ref-type="bibr">33</xref>], and here we observed this again, with 74% of cells exhibiting a spiking plateau, while 26% exhibited no spiking plateau (<bold><xref rid="pone.0316262.g001" ref-type="fig">Fig 1C</xref></bold>).</p></sec><sec id="sec011"><title>Effects of ketamine on muscarinic plateau potentials</title><p>We then proceeded to test the effect of general anaesthetics on the plateau potential. Ketamine is noted for exerting a variety of clinical effects, as a psychedelic, an antidepressant, and an anaesthetic, depending on the dose [<xref rid="pone.0316262.ref089" ref-type="bibr">89</xref>]. It is currently unclear what the effective concentration of ketamine is in the brain for a given intravenous or intraperitoneal dose (see the <xref rid="sec013" ref-type="sec">Discussion</xref>). For these reasons, we tested 20 &#956;M and 100 &#956;M of ketamine, applied after induction of muscarinic plateaus.</p><p>We first used wash-in (bath application) of ketamine. After wash-in of 20 &#956;M ketamine (<xref rid="pone.0316262.g002" ref-type="fig"><bold>Fig 2Aii</bold> and <bold>2B</bold></xref>) we found no significant difference in the change in the plateau area (MWU; 0 &#956;M: -26.6&#177;21.7 mV*s, n = 6; 20 &#956;M: -20.3&#177;9.6 mV*s, n = 16, p = 0.91) or spike number (MWU; 0 &#956;M: -19&#177;15 spikes, n = 6; 20 &#956;M: -14&#177;7.5 spikes, n = 16, p = 0.97) (<bold><xref rid="pone.0316262.g002" ref-type="fig">Fig 2Ci-ii</xref></bold>).</p><p>However, we found that the mean number of spikes triggered by each PP was reduced, although not significantly, following the wash-in of a higher concentration (100 &#956;M) of ketamine (<xref rid="pone.0316262.g002" ref-type="fig"><bold>Fig 2Aiii</bold> and <bold>2B</bold></xref>; MWU; 0 &#956;M: -19&#177;15 spikes, n = 6; 100 &#956;M: -49&#177;13 spikes, n = 7, p = 0.10), compared to control cells that were recorded for the same length of time without ketamine (i.e., 0 &#956;M).</p><p>The mean area of the PPs was also substantially reduced (<xref rid="pone.0316262.g002" ref-type="fig"><bold>Fig 2Aii</bold> and <bold>2B</bold></xref>), although the difference was not found to be statistically significant within our sample of 7 cells (<bold><xref rid="pone.0316262.g002" ref-type="fig">Fig 2Ci-ii</xref></bold>; MWU; 0 &#956;M: -26.6&#177;21.7 mV*s, n = 6; 100 &#956;M: -80.2&#177;24.6 mV*s, n = 7, p = 0.45). The effects of ketamine on the plateau and spike number were not readily reversible with wash-out for 5 minutes (<bold><xref rid="pone.0316262.g002" ref-type="fig">Fig 2B</xref></bold>), perhaps due to the partially lipophilic nature of ketamine [<xref rid="pone.0316262.ref090" ref-type="bibr">90</xref>].</p><p>In addition, we performed wash-in experiments with lower ketamine concentrations, as well as testing with 20 &#956;M of ketamine from a different producer, i.e., Ketalar&#8482; which is often used clinically. The results obtained were consistent with those from our other experiments with ketamine (see <xref rid="pone.0316262.s001" ref-type="supplementary-material">S1 Fig</xref>).</p><p>Next, we used prolonged pre-incubation of the slices with different concentrations of ketamine for 2 hours, before inducing PPs with muscarine (<bold><xref rid="pone.0316262.g003" ref-type="fig">Fig 3</xref></bold>), to test whether the long ketamine incubation would change the effect on the plateaus and spiking. Since centrally acting anaesthetic drugs (including ketamine and propofol) are lipophilic, diffusion from the bath into the slice may be slower than occurs through delivery from the extensive network of perfused capillaries <italic toggle="yes">in vivo</italic>. Thus, Geiger et al [<xref rid="pone.0316262.ref088" ref-type="bibr">88</xref>] found that in brain slices, ketamine can take up to 40 minutes to fully equilibrate in the tissue. Therefore, we decided to use an extended pre-incubation to achieve equilibrium.</p><p>We incubated slices in ketamine for 2 hours before transferring them to the recording chamber where the ketamine concentration was maintained, before muscarine was added to elicit a plateau. Plateaus were observed following pre-incubation in 0 &#956;M, 20 &#956;M and 100 &#956;M ketamine (<bold><xref rid="pone.0316262.g003" ref-type="fig">Fig 3A</xref></bold>), but occurred less often after 100 &#956;M incubation (spiking plateaus in 42% of cells tested) than in control, whereas there was little difference between incubation without ketamine (0 &#956;M: 73% showed plateaus) and with 20 &#956;M ketamine (80% showed plateaus) (<bold><xref rid="pone.0316262.g003" ref-type="fig">Fig 3B</xref></bold>).</p><p>The plateaus in cells incubated in 100 &#956;M ketamine were also significantly smaller than those in cells incubated without (0 &#956;M) and with 20 &#956;M ketamine, with both a smaller area (MWU test; 0 &#956;M: 100.3&#177;15.9 mV*s, n = 12; 20 &#956;M: 127.0&#177;24.3 mV*s, n = 10; 100 &#956;M: 47.2&#177;11.7 mV*s, n = 12; 0 &#956;M vs. 100 &#956;M: p = 0.02; 20 &#956;M vs. 100 &#956;M: p = 0.02) <bold>(<xref rid="pone.0316262.g003" ref-type="fig">Fig 3Ci</xref></bold>) and fewer spikes (MWU test; 0 &#956;M: 66&#177;12 spikes, n = 12; 20 &#956;M: 64&#177;18 spikes, n = 10; 100 &#956;M: 17&#177;8.7 spikes, n = 12; 0 &#956;M vs. 100 &#956;M: p = 0.04; 20 &#956;M vs. 100 &#956;M: p = 0.13) (<bold><xref rid="pone.0316262.g003" ref-type="fig">Fig 3Cii</xref></bold>). The plateaus in cells incubated in 20 &#956;M ketamine were not significantly different in size from those in cells incubated without (0 &#956;M) ketamine, either in area (p = 0.28) or spike number (p = 0.79). However, the mean values of plateau area and spike frequency were larger after preincubation with 20 &#956;M ketamine than without ketamine (<bold><xref rid="pone.0316262.g003" ref-type="fig">Fig 3Ci-ii</xref></bold>). Given our limited cell number (n = 12, 10, and 12, for 0, 20, and 100 &#956;M respectively), we do not know whether the surprising, apparent increase in plateau size and spiking was a real, concentration-dependent ketamine effect, or due to chance, including sampling from different subpopulations of L2/3PCs (see <xref rid="sec013" ref-type="sec">discussion</xref>).</p></sec><sec id="sec012"><title>Effects of propofol on muscarinic plateaus</title><p>We then tested the effects of propofol on the muscarinic plateaus. Wash-in of 3 &#956;M propofol led to an observed slight reduction in the plateau, whilst 10 &#956;M led to a larger reduction (<xref rid="pone.0316262.g004" ref-type="fig"><bold>Fig 4A</bold> and <bold>4B</bold></xref>).</p><p>Whilst there was no significant difference in the change in the area (MWU test; 0 &#956;M: -18.1&#177;9.5 mV*s, n = 10; 3 &#956;M: -25.7&#177;10.0 mV*s, n = 8; 10 &#956;M: -57.9&#177;17.8 mV*s, n = 10; 0 &#956;M vs. 3 &#956;M: p = 0.46; 0 &#956;M vs. 10 &#956;M: p = 0.14) following propofol wash-in of either 3 &#956;M or 10 &#956;M compared to 0 &#956;M (<bold><xref rid="pone.0316262.g004" ref-type="fig">Fig 4Ci</xref></bold>), wash-in of both 3 &#956;M and 10 &#956;M reduced the number of plateau spikes (MWU test; 0 &#956;M: 5.4&#177;9.8 spikes, n = 10; 3 &#956;M: -22&#177;8.7 spikes, n = 8; 10 &#956;M: -27&#177;12 spikes, n = 10; 0 &#956;M vs. 3 &#956;M: p = 0.04; 0 &#956;M vs. 10 &#956;M: p = 0.048) significantly compared to 0 &#956;M (<bold><xref rid="pone.0316262.g004" ref-type="fig">Fig 4C</xref></bold>).</p><p>As with ketamine we wished to compare the effect on muscarinic plateaus following incubation in propofol, which is of even greater importance as propofol is highly lipophilic, and it has been observed previously that it can take long periods to penetrate into and accumulate in brain slice preparations similar to those we used [<xref rid="pone.0316262.ref087" ref-type="bibr">87</xref>].</p><p>Following a two-hour incubation in 3 &#956;M propofol plateaus were noticeably smaller (<bold><xref rid="pone.0316262.g005" ref-type="fig">Fig 5A</xref></bold>), and a smaller proportion of cells exhibited a spiking plateau (spiking plateaus in 44% of cells tested) when compared to cells from slices which had been incubated in standard aCSF (spiking plateaus in 73%; <bold><xref rid="pone.0316262.g005" ref-type="fig">Fig 5B</xref></bold>). The plateaus in propofol-incubated cells also declined more strongly over time than in control cells (<bold><xref rid="pone.0316262.g005" ref-type="fig">Fig 5C</xref></bold>). Cells incubated in 3 &#956;M propofol had significantly fewer spikes (MWU test; 0 &#956;M: 66&#177;12 spikes, n = 12; 3 &#956;M: 16&#177;5.9 spikes, n = 16, p = 0.005), but not significantly different post-burst area (MWU test; 0 &#956;M: 100&#177;15.9 mV*s, n = 12; 3 &#956;M: 50.1&#177;11.3, n = 16, p = 0.06) after wash-in of muscarine, compared to those incubated in control aCSF (<bold><xref rid="pone.0316262.g005" ref-type="fig">Fig 5Di</xref></bold> and <bold>ii</bold>).</p></sec></sec><sec sec-type="conclusions" id="sec013"><title>Discussion</title><p>In this study, we first confirmed that plateau potentials (PPs), often triggering action potentials, are induced by the metabotropic cholinergic agonist muscarine in layer 2/3 pyramidal cells (L2/3PCs) in slices from the rat prefrontal cortex (PFC), as we found previously [<xref rid="pone.0316262.ref033" ref-type="bibr">33</xref>].</p><p>The main result of this study, however, is that it shows, for the first time to our knowledge, that the general anaesthetics propofol and ketamine attenuate the muscarinic PPs in rat PFC L2/3PCs, in a dose- and time-dependent manner. We suggest that these results may possibly be related to some of the anaesthetic effects of these drugs <italic toggle="yes">in vivo</italic>, because induction of PPs is a particularly prominent cellular effect of acetylcholine, which in turn is known to be highly important for wakefulness.</p><p>Our study also supports the conclusions (as one of few studies in the literature, as far as we know [<xref rid="pone.0316262.ref087" ref-type="bibr">87</xref>]), that propofol requires extremely long time for equilibration by diffusion in slice experiments, and is also prone to stick to several types of plastic and rubber tubing that are often used in brain slice experiments. We hope this provides useful practical information for other researchers and future experiments.</p><p>These results were obtained by testing the anaesthetics before and after bath-applying the &#8220;arousing&#8221; agonist muscarine, in order to partly mimic an &#8220;aroused&#8221;- or &#8220;awake-like&#8221; state in the cortical slices (the &#8220;arousal-first approach&#8221;). To our knowledge, this exact approach has not previously been used to study single-cell intrinsic neuronal mechanisms of anaesthetics <italic toggle="yes">in vitro</italic>, although cholinergic agonists have been used by others in order to study effects of anaesthetics in brain slices on <italic toggle="yes">in vivo</italic>-like oscillations and synaptic transmission, as well as cholinergic intoxication. As described in the Introduction, cholinergic stimulation has been used to induce theta- and gamma-like network oscillations in hippocampal and cortical slices [<xref rid="pone.0316262.ref024" ref-type="bibr">24</xref>&#8211;<xref rid="pone.0316262.ref026" ref-type="bibr">26</xref>,<xref rid="pone.0316262.ref028" ref-type="bibr">28</xref>,<xref rid="pone.0316262.ref091" ref-type="bibr">91</xref>&#8211;<xref rid="pone.0316262.ref093" ref-type="bibr">93</xref>]. Some of these studies [<xref rid="pone.0316262.ref025" ref-type="bibr">25</xref>,<xref rid="pone.0316262.ref026" ref-type="bibr">26</xref>] used carbachol and bicuculline to mimic ascending cholinergic and GABAergic inputs. Drexler et al. [<xref rid="pone.0316262.ref094" ref-type="bibr">94</xref>] used cholinergic overstimulation with soman and acetylcholine in organotypic cortical slices to test how the efficacy of propofol is affected by intoxication.</p><p>For our purpose, to partly mimic an &#8220;aroused-like&#8221; state in vitro before testing anaesthetics, we used muscarine, because muscarinic acetylcholine receptors (mAChR) are known to mediate particularly powerful &#8220;arousal&#8221; effects in cortical pyramidal cells, including PP generation [<xref rid="pone.0316262.ref071" ref-type="bibr">71</xref>,<xref rid="pone.0316262.ref073" ref-type="bibr">73</xref>,<xref rid="pone.0316262.ref095" ref-type="bibr">95</xref>].</p><p>It is however difficult to clarify how, and to what extent, the effects of anaesthetic drugs in isolated brain slices can be translated into anaesthetic effects of those drugs <italic toggle="yes">in vivo</italic>, including clinical general anaesthesia (GA) in humans. Below we discuss this issue, after first describing the &#8220;arousal-first approach&#8221; and the induction of PPs by muscarine.</p><sec id="sec014"><title>The &#8220;arousal-first approach&#8221;: using muscarine to induce a partly &#8220;aroused-like&#8221; state in brain slices before testing anaesthetic drugs</title><p>When testing cellular effects of general anaesthetics <italic toggle="yes">in vitro</italic>, one would ideally like to first induce an &#8220;aroused-&#8221; or &#8220;awake-like&#8221; state in the cells by applying a cocktail of relevant neurochemicals needed for such a state. However, as discussed in the Introduction, it is currently technically impossible to closely mimic, <italic toggle="yes">in vitro</italic>, the complex temporo-spatial patterns of multiple neuromodulators underlying the normal awake state at cortical neurons of the intact brain. Instead, we used a highly simplified, easily controllable &#8220;partial arousal-first approach&#8221;, adding only a single, powerfully arousing agonist: muscarine. Although not ideal, we think that this approach is considerably more fruitful for testing anaesthetic drugs <italic toggle="yes">in vitro</italic>, than just testing in brain slices or cells that are profoundly depleted of nearly all arousing modulation, as has been done in several previous <italic toggle="yes">in vitro</italic> studies of anaesthetic drug effects [<xref rid="pone.0316262.ref010" ref-type="bibr">10</xref>&#8211;<xref rid="pone.0316262.ref016" ref-type="bibr">16</xref>].</p><p>The &#8220;arousal-first approach&#8221; allows testing for effects of anaesthetics on neuronal mechanisms that are likely present in the awake brain <italic toggle="yes">in vivo</italic>, but not found in regular brain slices lacking such neuromodulation. In particular, this approach allowed us to test the effects of anaesthetics on the prominent muscarinic PPs, which profoundly alters the input-output function of rat PFC L2/3PCs [<xref rid="pone.0316262.ref033" ref-type="bibr">33</xref>]. Similarly profound muscarinic effects have also been found in several other cortical pyramidal neuron types [<xref rid="pone.0316262.ref073" ref-type="bibr">73</xref>,<xref rid="pone.0316262.ref095" ref-type="bibr">95</xref>]. Given the high level of ACh release in the neocortex during conscious brain states <italic toggle="yes">in vivo</italic>, both in wakefulness and dream sleep [<xref rid="pone.0316262.ref068" ref-type="bibr">68</xref>,<xref rid="pone.0316262.ref096" ref-type="bibr">96</xref>,<xref rid="pone.0316262.ref097" ref-type="bibr">97</xref>], it seems likely that such PPs in PFC L2/3PCs are a normal feature of the awake, conscious brain, and may contribute strongly to both awake and dreaming states.</p><p>It may be noted that, in spite of similarities, there are also some differences between our approach, and that of Lukatch &amp; MacIver [<xref rid="pone.0316262.ref026" ref-type="bibr">26</xref>], who focused on network activity and combined carbachol with a GABA<sub>A</sub>-blocker to mimic local disinhibition. They also found that the theta-like oscillations were blocked by glutamate receptor (GluR) blockers. In contrast, because we focused on intrinsic, non-synaptic, neuronal mechanisms only, we used GABA<sub>A</sub>- and GluR-blockers (gabazine, DNQX, APV) simply to get rid of ionotropic synaptic transmission, in order to test the intrinsic PPs in synaptically isolated neurons.</p><p>To our knowledge, no previous study used such an <italic toggle="yes">&#8220;arousal first approach</italic>&#8221; <italic toggle="yes">in vitro</italic> to test effects of anaesthetics on intrinsic neuronal mechanisms.</p></sec><sec id="sec015"><title>Muscarine reliably induced plateau potentials (PPs) in PFC L2/3PCs</title><p>We observed that 10 &#956;M muscarine induced spiking PPs in the majority of PFC L2/3PCs without pre-incubation with an anaesthetic (<bold><xref rid="pone.0316262.g001" ref-type="fig">Fig 1C</xref></bold>, 74%), thus confirming our previous result [<xref rid="pone.0316262.ref033" ref-type="bibr">33</xref>]. However, this incidence of eliciting a spiking PP with 10 &#956;M muscarine after regular incubation was lower than the 100% incidence that we found in our previous study. This might be due to the larger number of L2/3PCs cells in this study (n = 127; <bold><xref rid="pone.0316262.g001" ref-type="fig">Fig 1C</xref></bold>) compared to the previous one (n = 10; [<xref rid="pone.0316262.ref033" ref-type="bibr">33</xref>], as the sample of cells tested here might include a greater diversity of cell phenotypes, i.e., subtypes of L2/3PCs [<xref rid="pone.0316262.ref098" ref-type="bibr">98</xref>].</p></sec><sec id="sec016"><title>Comparing relevant drug concentrations and effects <italic toggle="yes">in vitro</italic> vs. <italic toggle="yes">in vivo</italic>. Long pre-incubation revealed effects of lower doses</title><p>It is difficult to know which concentrations of anaesthetics to use in slice experiments in order to mimic clinically relevant drug concentrations within the human or animal brain during general anaesthesia. The difficulties stem in part from the complex pharmacokinetics of anaesthetic drugs, including binding to proteins and lipids, as well as diffusion barriers and delays, resulting in large differences between the different compartments (blood vs. brain compartments, water vs. lipid phases, etc.) and between total and effective free drug concentration within each compartment. Also, differences between species in drug sensitivity may be relevant. As it is currently not possible to directly measure anaesthetic drug concentrations at the sites of actions in the human brain, these concentrations have to be inferred from models [<xref rid="pone.0316262.ref099" ref-type="bibr">99</xref>]. Unfortunately, these issues are often not clearly or explicitly addressed in the available literature. It often seems unclear exactly which concentrations, compartments and conditions authors are referring to. In addition, reported values vary considerably (e.g. Hijazi and Boulieu [<xref rid="pone.0316262.ref100" ref-type="bibr">100</xref>]; Dayton et al. [<xref rid="pone.0316262.ref101" ref-type="bibr">101</xref>]; Ishii-Maruhama et al. [<xref rid="pone.0316262.ref102" ref-type="bibr">102</xref>]; Franks and Lieb [<xref rid="pone.0316262.ref103" ref-type="bibr">103</xref>]. See <bold><xref rid="pone.0316262.s002" ref-type="supplementary-material">S1 File</xref></bold> for a more detailed discussion of these issues.</p></sec><sec id="sec017"><title>Effects of ketamine <italic toggle="yes">in vitro</italic> vs. <italic toggle="yes">in vivo</italic></title><p>We saw no significant effect on PPs of relatively low ketamine (20 &#956;M), neither with wash-in nor pre-incubation (<bold>Figs <xref rid="pone.0316262.g002" ref-type="fig">2</xref></bold> and <bold><xref rid="pone.0316262.g003" ref-type="fig">3</xref></bold>). In previous <italic toggle="yes">in vitro</italic> experiments with ketamine in rodent CNS slices, a wide range of concentrations have been used, from 30 nM to 10 mM free ketamine [<xref rid="pone.0316262.ref012" ref-type="bibr">12</xref>,<xref rid="pone.0316262.ref016" ref-type="bibr">16</xref>,<xref rid="pone.0316262.ref104" ref-type="bibr">104</xref>]. Studies in humans have estimated that full unresponsiveness to both verbal command and pain caused by ketamine alone requires at least 3&#8211;4 &#956;M total ketamine in the blood (Sch&#252;ttler et al. 1987), yielding ~2 &#956;M free ketamine in blood (assuming ~50% protein binding; Dayton et al. 1983). According to one kind of estimate based on these human data and simplifying assumptions, our <italic toggle="yes">in vitro</italic> concentration of 20 &#956;M free ketamine (<bold>Figs <xref rid="pone.0316262.g002" ref-type="fig">2</xref></bold> and <bold><xref rid="pone.0316262.g003" ref-type="fig">3</xref></bold>) may be about 10 times higher than the <italic toggle="yes">in vivo</italic> concentration of free ketamine in the human brain required for full surgical anaesthesia with ketamine alone. However, another estimate, based on <italic toggle="yes">in vivo</italic> data from rodents [<xref rid="pone.0316262.ref105" ref-type="bibr">105</xref>&#8211;<xref rid="pone.0316262.ref108" ref-type="bibr">108</xref>], may suggest a free brain concentration of ketamine during full anaesthesia of 20&#8211;100 &#956;M, resembling the 20&#8211;100 &#956;M free concentrations that we used in the aCSF for our wash-in and pre-incubation experiments (<bold>Figs <xref rid="pone.0316262.g002" ref-type="fig">2</xref></bold> and <bold><xref rid="pone.0316262.g003" ref-type="fig">3</xref></bold>). One possibility is that rodents may require a higher free brain concentration of ketamine than humans for full anaesthesia [<xref rid="pone.0316262.ref109" ref-type="bibr">109</xref>]. It should be noted that the IV starting dose to induce general anaesthesia in humans is typically 3&#8211;4 mg/kg [<xref rid="pone.0316262.ref110" ref-type="bibr">110</xref>] whereas the IP doses in rodents mentioned above are ~10&#8211;190 mg/kg. The above wide ranges may also reflect that it is very difficult to determine the exact minimal dose of ketamine for full anaesthesia caused by ketamine alone in rodents; hence some reported values may be far too high. In addition, IV injections seem to be much more effective than IP injections of similar ketamine doses in rodents, probably reflecting slower and incomplete absorption into the blood from IP injections. These multiple issues and diverging estimates illustrate the difficulties in choosing appropriate concentrations of anaesthetics for use in slice experiments. See <bold><xref rid="pone.0316262.s002" ref-type="supplementary-material">S1 File</xref></bold> for a more detailed discussion.</p></sec><sec id="sec018"><title>Possible relevance of our <italic toggle="yes">in vitro</italic> results with ketamine to anaesthetic and other effects <italic toggle="yes">in vivo</italic></title><p>The estimates based on <italic toggle="yes">in vivo</italic> ketamine anaesthesia in rodents (20&#8211;100 &#956;M free ketamine in the brain) suggest that the different effects on PPs that we found between these concentrations (100 &#956;M ketamine reduced the PPs, whereas 20 &#956;M had little or no effects on the PPs: <bold>Figs <xref rid="pone.0316262.g002" ref-type="fig">2</xref></bold> and <bold><xref rid="pone.0316262.g003" ref-type="fig">3</xref></bold>), may be relevant for the <italic toggle="yes">in vivo</italic> anaesthetic effects of ketamine in rodents, and possibly also in humans. Furthermore, this reasoning, based on rodent data, may suggest that the plateau suppression that we saw at higher but not lower ketamine concentrations (<bold>Figs <xref rid="pone.0316262.g002" ref-type="fig">2</xref></bold> and <bold><xref rid="pone.0316262.g003" ref-type="fig">3</xref></bold>) may contribute to the suppression of responsiveness combined with altered &#8220;inner&#8221; consciousness seen at anaesthetic doses in humans [<xref rid="pone.0316262.ref009" ref-type="bibr">9</xref>].</p><p>Clearly, although propofol and ketamine are known to affect GABA<sub>A</sub> and NMDA receptor/channels, respectively, these effects probably did not contribute to the effects on PPs that we report here, since we did not use synaptic stimulation and also because we used GABA<sub>A</sub> and NMDA receptor blockers (gabazine, DNQX and APV) throughout most of our experiments. Thus, although the effects of propofol and ketamine on GABA<sub>A</sub> and NMDA receptors are probably highly important for the anaesthetic effects <italic toggle="yes">in vivo</italic>, the effects on the &#8220;intrinsic&#8221; (non-synaptic) PPs are presumably an additional mechanism that adds to the known synaptic mechanisms, as well as to distinct intrinsic mechanisms in other neuron types, such as the uncoupling between apical and basal compartments in L5 pyramidal cells [<xref rid="pone.0316262.ref054" ref-type="bibr">54</xref>].</p></sec><sec id="sec019"><title>Apparent bimodal concentration-dependence of ketamine effects on PPs: Possible relevance for consciousness?</title><p>We found that the mean values of the PP area and spike frequency were somewhat larger after preincubation with 20 &#956;M ketamine than without ketamine (<bold><xref rid="pone.0316262.g003" ref-type="fig">Fig 3Ci-ii</xref></bold>). This might suggest that relatively low ketamine concentrations increased the plateaus whereas higher concentrations reduced the plateaus, thus suggesting a bimodal, concentration-dependent ketamine effect. We do not know whether this surprising pattern is real or due to chance, or might reflect different subpopulations of L2/3PCs that we could not distinguish due to small sample sizes [<xref rid="pone.0316262.ref111" ref-type="bibr">111</xref>]. However, if there is really such a bimodal concentration-dependence of the ketamine effect on the PPs, it seems to fit well with certain observations of seemingly bimodal, concentration-dependent effects of ketamine <italic toggle="yes">in vivo</italic> both in humans [<xref rid="pone.0316262.ref112" ref-type="bibr">112</xref>] and in rodents [<xref rid="pone.0316262.ref113" ref-type="bibr">113</xref>].</p><p>The apparent enhancing effect on PPs of relatively low ketamine (20 &#956;M) in both wash-in and pre-incubation experiments (<bold>Figs <xref rid="pone.0316262.g002" ref-type="fig">2</xref></bold> and <bold><xref rid="pone.0316262.g003" ref-type="fig">3</xref></bold>), may suggest that low ketamine doses may exert their potential antidepressant effects [<xref rid="pone.0316262.ref089" ref-type="bibr">89</xref>] by enhancing PPs and persistent firing. This possibility may be supported by evidence suggesting that sub-anaesthetic, antidepressant ketamine doses cause a hyperglutamatergic state in the PFC, in contrast to anaesthetic doses which decrease PFC glutamate levels [<xref rid="pone.0316262.ref114" ref-type="bibr">114</xref>]. This again suggests a bimodal concentration-dependence, which might be related to an enhanced PP-driven firing and glutamate release induced by low ketamine (<bold><xref rid="pone.0316262.g003" ref-type="fig">Fig 3Ci-ii</xref></bold>).</p></sec><sec id="sec020"><title>Effects of propofol <italic toggle="yes">in vitro</italic> vs. <italic toggle="yes">in vivo</italic></title><p>The total blood plasma concentrations of propofol during surgical anaesthesia in humans have been estimated to be ~3&#8211;27 &#956;g/ml [<xref rid="pone.0316262.ref115" ref-type="bibr">115</xref>,<xref rid="pone.0316262.ref116" ref-type="bibr">116</xref>], which converts to ~16&#8211;153 &#956;M. However, this range reflects large differences between &#8220;unresponsiveness&#8221; to speech (required 5.4 &#956;g/ml propofol) vs. pain (required 27 &#956;g/ml) induced by propofol alone. Since propofol is ~95&#8211;97% bound to plasma proteins [<xref rid="pone.0316262.ref117" ref-type="bibr">117</xref>], the 3 &#956;M propofol used in our ACSF for slice experiments (<bold>Figs <xref rid="pone.0316262.g004" ref-type="fig">4</xref></bold> and <bold><xref rid="pone.0316262.g005" ref-type="fig">5</xref></bold>) may be close to the concentration range relevant in humans for deep general anaesthesia and analgesia with propofol only. However, this dosage is almost never used for clinical surgery, as propofol is normally used at 3&#8211;4 &#956;g/ml total in plasma (~0.5 &#956;M free propofol) for verbal unconsciousness, supplemented with another drug for analgesic unresponsiveness. In general, available evidence suggests that <italic toggle="yes">in vitro</italic> experiments often require higher drug concentrations than <italic toggle="yes">in vivo</italic>, but the mechanisms are complex and often poorly understood [<xref rid="pone.0316262.ref118" ref-type="bibr">118</xref>,<xref rid="pone.0316262.ref119" ref-type="bibr">119</xref>].</p></sec><sec id="sec021"><title>Long pre-incubation of propofol was needed to reveal effects of lower doses</title><p>A major difference between intravenous administration of ketamine or propofol <italic toggle="yes">in vivo</italic> and our bath application of these drugs <italic toggle="yes">in vitro</italic>, is that brain slices of course lack the <italic toggle="yes">in vivo</italic> blood supply through a dense capillary net, which brings drugs rapidly to within a few micrometres from each brain cell, requiring minimal diffusion time. This difference proved to be particularly important for propofol and probably explains its far slower equilibration in slices.</p><p>In line with this reasoning, our experiments using 2 hours of pre-incubation with relatively low concentrations of propofol (3 &#956;M) or ketamine (20 &#956;M) showed considerably stronger drug effects than our wash-in experiments applying the same drug concentrations for 5&#8211;25 minutes. This difference was especially striking for propofol (compare <bold>Figs <xref rid="pone.0316262.g002" ref-type="fig">2</xref></bold> and <bold><xref rid="pone.0316262.g003" ref-type="fig">3</xref></bold> for ketamine, and <bold>Figs <xref rid="pone.0316262.g004" ref-type="fig">4</xref></bold> and <bold><xref rid="pone.0316262.g005" ref-type="fig">5</xref></bold> for propofol). This strongly suggests that our wash-in applications did not reveal the full effect of the applied drug concentrations, presumably because of delayed equilibration between the medium and the slice. This interpretation is strongly supported by studies of diffusion of ketamine and propofol [<xref rid="pone.0316262.ref087" ref-type="bibr">87</xref>,<xref rid="pone.0316262.ref088" ref-type="bibr">88</xref>]. Therefore, our discussion and conclusions are primarily based on our 2 h pre-incubation results.</p></sec><sec id="sec022"><title>Effects of ketamine and propofol on PPs vs. states of consciousness</title><p>How may the effects of ketamine and propofol on PPs be related to the different effects of these drugs on states of unconsciousness? The similar suppression of PPs by high ketamine and high propofol and the seemingly contrasting effects of lower doses, seem compatible with the idea that PPs may be more related to conscious experience than to responsiveness. Ketamine promotes vivid dreaming and seemingly also enhances PPs, unlike propofol, whilst responsiveness is reduced by both drugs [<xref rid="pone.0316262.ref042" ref-type="bibr">42</xref>,<xref rid="pone.0316262.ref104" ref-type="bibr">104</xref>]. PP-mediated effects may thus possibly contribute to the many synaptic and non-synaptic mechanisms of anaesthesia that affect consciousness [<xref rid="pone.0316262.ref001" ref-type="bibr">1</xref>,<xref rid="pone.0316262.ref067" ref-type="bibr">67</xref>,<xref rid="pone.0316262.ref105" ref-type="bibr">105</xref>], as suggested by accumulating evidence and theories spanning widely different levels (e.g. Aru et al. [<xref rid="pone.0316262.ref082" ref-type="bibr">82</xref>]; Storm et al. [<xref rid="pone.0316262.ref120" ref-type="bibr">120</xref>]).</p></sec></sec><sec id="sec023"><title>Summary and conclusions</title><p>We used whole-cell patch clamp recordings to compare the effects of two different general anaesthetics, ketamine and propofol, in L2/3 pyramidal cells in prefrontal rat cortical brain slices. Attempting to induce a partially &#8220;aroused&#8221; state, we pre-treated the slices with muscarine, which caused depolarising plateau potentials (PPs) with spiking.</p><p>After a long (2 hour) pre-incubation with 20 &#956;M ketamine or 3 &#956;M propofol, assumed to be close to equipotent doses in rats, the muscarine-induced PPs were altered in apparently different ways: 3 &#956;M propofol significantly reduced the PP-evoked spiking and reduced the mean PPs area (non-significant). In contrast, 20 &#956;M ketamine was followed by an apparent (non-significant) increase in the PPs. A possible relation between these apparently different effects of ketamine and propofol and their contrasting clinical effects is discussed.</p><p>We also tested a briefer wash-in (5&#8211;25 min) of ketamine or propofol. Higher concentrations of ketamine (100 &#956;M) or propofol (10 &#956;M), which are known to cause deeper anaesthesia <italic toggle="yes">in vivo</italic>, both suppressed PPs and spiking. Propofol (3 &#956;M) but not ketamine (20 &#956;M) significantly reduced the spike frequency, and we found no significant changes in mean PPs, perhaps reflecting insufficient equilibration by diffusion into the slices.</p><p>Choosing concentrations and timing of anaesthetics for <italic toggle="yes">in vitro</italic> slice experiments is a complex issue, and much remains to be clarified as to relevance for <italic toggle="yes">in vivo</italic> human anaesthesia. Based on simplifying, uncertain assumptions, the concentrations we used <italic toggle="yes">in vitro</italic> appear to be somewhat higher than those normally used in clinical human anaesthesia. More experiments are needed to test our tentative conclusions, including the apparent enhancement of PPs by 20 &#956;M ketamine.</p></sec><sec id="sec024" sec-type="supplementary-material"><title>Supporting information</title><supplementary-material id="pone.0316262.s001" position="float" content-type="local-data" orientation="portrait"><label>S1 Fig</label><caption><p>A) Time course plots showing the normalised area (i) and spikes (ii) following the wash-in of muscarine and then the subsequent 5-minute wash-in, then wash-out of ketamine (and Ketalar, a clinically used preparation with ketamine as its active ingredient) at different concentrations (0 &#956;M: n = 6; 2 &#956;M: n = 6; 10 &#956;M: n = 6; 20 &#956;M: n = 16; 100 &#956;M; n = 7; 20 &#956;M Ketalar: n = 4; Error bars = SEM). B) Summary plots of the change in area (i) and spikes (ii) following application of ketamine at different concentrations, relative to prior to the wash-in of ketamine in the presence of muscarine. (i) Neither the change in the post-burst area nor in the post-burst spiking was significantly different at any of the tested ketamine or Ketalar concentrations relative to the change in the control group (MWU test; 0 &#956;M: -26.6 &#177; 21.7 mV*s, n = 6; 2 &#956;M: -48.3 &#177; 25.7 mV*s, n = 6; 10 &#956;M: -35.1 &#177; 17.1 mV*s, n = 6; 20 &#956;M: -20.3 &#177; 9,7 mV*s, n = 16; 100 &#956;M: -80.2 &#177; 24.6 mV*s, n = 7; 20 &#956;M Ketalar: -25.8 &#177; 23.5 mV*s, n = 4; 0 &#956;M vs. 2 &#956;M: p = 0.70; 0 &#956;M vs. 10 &#956;M: p = 0.82; 0 &#956;M vs. 20 &#956;M; p = 0.91; 0 &#956;M vs. 100 &#956;M: p = 0.45; 0 &#956;M vs. 20 &#956;M Ketalar: p&gt;0.99). Error bars = 95% CI. ns = p&gt;0.05.</p><p>(TIF)</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="pone.0316262.s001.tif" position="float" orientation="portrait"/></supplementary-material><supplementary-material id="pone.0316262.s002" position="float" content-type="local-data" orientation="portrait"><label>S1 File</label><caption><p>(DOCX)</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="pone.0316262.s002.docx" position="float" orientation="portrait"/></supplementary-material><supplementary-material id="pone.0316262.s003" position="float" content-type="local-data" orientation="portrait"><label>S1 Data</label><caption><p>(XLSX)</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="pone.0316262.s003.xlsx" position="float" orientation="portrait"/></supplementary-material></sec></body><back><ack><p>We would like to thank our colleague Dr. Christoph H&#246;nigsperger for his comments, and Cecilie Oksvold for her technical assistance. We would also like to thank the reviewers for their valuable comments, which have helped us improve our manuscript.</p></ack><ref-list><title>References</title><ref id="pone.0316262.ref001"><label>1</label><mixed-citation publication-type="book"><name name-style="western"><surname>Smith G</surname></name>, <name name-style="western"><surname>D&#8217;Cruz</surname><given-names>JR</given-names></name>, <name name-style="western"><surname>Rondeau</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Goldman</surname><given-names>J</given-names></name>. <source>General Anesthesia for Surgeons.</source> In: <source>StatPearls</source>. <publisher-loc>Treasure Island (FL)</publisher-loc>: <publisher-name>StatPearls Publishing</publisher-name>; <year>2023</year>.<pub-id pub-id-type="pmid">29630251</pub-id></mixed-citation></ref><ref id="pone.0316262.ref002"><label>2</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Franks</surname><given-names>NP</given-names></name>. <article-title>General anaesthesia: from molecular targets to neuronal pathways of sleep and arousal.</article-title><source>Nat Rev Neurosci.</source><year>2008</year><month>May</month>;<volume>9</volume>(<issue>5</issue>):<fpage>370</fpage>&#8211;<lpage>86</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/nrn2372</pub-id><pub-id pub-id-type="pmid">18425091</pub-id></mixed-citation></ref><ref id="pone.0316262.ref003"><label>3</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Alkire</surname><given-names>MT</given-names></name>, <name name-style="western"><surname>Hudetz</surname><given-names>AG</given-names></name>, <name name-style="western"><surname>Tononi</surname><given-names>G</given-names></name>. <article-title>Consciousness and anesthesia.</article-title><source>Science</source>. <year>2008</year><month>Nov</month><day>7</day>;<volume>322</volume>(<issue>5903</issue>):<fpage>876</fpage>&#8211;<lpage>80</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1126/science.1149213</pub-id><pub-id pub-id-type="pmid">18988836</pub-id><pub-id pub-id-type="pmcid">PMC2743249</pub-id></mixed-citation></ref><ref id="pone.0316262.ref004"><label>4</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Phillips</surname><given-names>WA</given-names></name>, <name name-style="western"><surname>Bachmann</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Storm</surname><given-names>JF</given-names></name>. <article-title>Apical function in neocortical pyramidal cells: A common pathway by which general anesthetics can affect mental state.</article-title><source>Front Neural Circuits.</source><year>2018</year><source>Jul 2</source>;<volume>12</volume>:<fpage>50</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.3389/fncir.2018.00050</pub-id><pub-id pub-id-type="pmid">30013465</pub-id><pub-id pub-id-type="pmcid">PMC6036169</pub-id></mixed-citation></ref><ref id="pone.0316262.ref005"><label>5</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Brown</surname><given-names>EN</given-names></name>, <name name-style="western"><surname>Purdon</surname><given-names>PL</given-names></name>, <name name-style="western"><surname>Van Dort</surname><given-names>CJ</given-names></name>. <article-title>General anesthesia and altered states of arousal: a systems neuroscience analysis</article-title>. <source>Annu Rev Neurosci</source>. <year>2011</year>;<volume>34</volume>:<fpage>601</fpage>&#8211;<lpage>28</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1146/annurev-neuro-060909-153200</pub-id><pub-id pub-id-type="pmid">21513454</pub-id><pub-id pub-id-type="pmcid">PMC3390788</pub-id></mixed-citation></ref><ref id="pone.0316262.ref006"><label>6</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Sanders</surname><given-names>RD</given-names></name>, <name name-style="western"><surname>Tononi</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Laureys</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Sleigh</surname><given-names>JW</given-names></name>. <article-title>Unresponsiveness &#8800; unconsciousness</article-title>. <source>Anesthesiology</source>. <year>2012</year>;<volume>116</volume>(<issue>4</issue>):<fpage>946</fpage>&#8211;<lpage>59</lpage>.<pub-id pub-id-type="pmid">22314293</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/ALN.0b013e318249d0a7</pub-id><pub-id pub-id-type="pmcid">PMC3311716</pub-id></mixed-citation></ref><ref id="pone.0316262.ref007"><label>7</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Collier</surname><given-names>BB</given-names></name>. <article-title>Ketamine and the conscious mind</article-title>. <source>Anaesthesia</source>. <year>1972</year><month>Apr</month>;<volume>27</volume>(<issue>2</issue>):<fpage>120</fpage>&#8211;<lpage>34</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1111/j.1365-2044.1972.tb08186.x</pub-id><pub-id pub-id-type="pmid">5021517</pub-id></mixed-citation></ref><ref id="pone.0316262.ref008"><label>8</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Grace</surname><given-names>RF</given-names></name>. <article-title>The effect of variable-dose diazepam on dreaming and emergence phenomena in 400 cases of ketamine-fentanyl anaesthesia.</article-title><source>Anaesthesia.</source><year>2003</year><source>Sep</source>;<volume>58</volume>(<issue>9</issue>):<fpage>904</fpage>&#8211;<lpage>10</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1046/j.1365-2044.2003.03341.x</pub-id><pub-id pub-id-type="pmid">12911367</pub-id></mixed-citation></ref><ref id="pone.0316262.ref009"><label>9</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Sarasso</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Boly</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Napolitani</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Gosseries</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Charland-Verville</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Casarotto</surname><given-names>S</given-names></name>, <etal>et al</etal>. <article-title>Consciousness and Complexity during Unresponsiveness Induced by Propofol, Xenon, and Ketamine.</article-title><source>Curr Biol</source>. <year>2015</year><month>Dec</month><day>7</day>;<volume>25</volume>(<issue>23</issue>):<fpage>3099</fpage>&#8211;<lpage>105</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.cub.2015.10.014</pub-id><pub-id pub-id-type="pmid">26752078</pub-id></mixed-citation></ref><ref id="pone.0316262.ref010"><label>10</label><mixed-citation publication-type="journal"><name name-style="western"><surname>MacIver</surname><given-names>MB</given-names></name>, <name name-style="western"><surname>Roth</surname><given-names>SH</given-names></name>. <article-title>Inhalation anaesthetics exhibit pathway-specific and differential actions on hippocampal synaptic responses in vitro</article-title>. <source>Br J Anaesth</source>. <year>1988</year><month>May</month>;<volume>60</volume>(<issue>6</issue>):<fpage>680</fpage>&#8211;<lpage>91</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/bja/60.6.680</pub-id><pub-id pub-id-type="pmid">2837263</pub-id></mixed-citation></ref><ref id="pone.0316262.ref011"><label>11</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Berg-Johnsen</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Langmoen</surname><given-names>IA</given-names></name>. <article-title>Mechanisms concerned in the direct effect of isoflurane on rat hippocampal and human neocortical neurons</article-title>. <source>Brain Res</source>. <year>1990</year><month>Jan</month><day>15</day>;<volume>507</volume>(<issue>1</issue>):<fpage>28</fpage>&#8211;<lpage>34</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/0006-8993(90)90517-f</pub-id><pub-id pub-id-type="pmid">2302577</pub-id></mixed-citation></ref><ref id="pone.0316262.ref012"><label>12</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Potez</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Larkum</surname><given-names>ME</given-names></name>. <article-title>Effect of common anesthetics on dendritic properties in layer 5 neocortical pyramidal neurons</article-title>. <source>J Neurophysiol</source>. <year>2008</year><month>Mar</month>;<volume>99</volume>(<issue>3</issue>):<fpage>1394</fpage>&#8211;<lpage>407</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1152/jn.01126.2007</pub-id><pub-id pub-id-type="pmid">18199815</pub-id></mixed-citation></ref><ref id="pone.0316262.ref013"><label>13</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Hoerbelt</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Heifets</surname><given-names>BD</given-names></name>. <article-title>Native System and Cultured Cell Electrophysiology for Investigating Anesthetic Mechanisms</article-title>. <source>Methods Enzymol</source>. <year>2018</year><month>Mar</month><day>20</day>;<volume>602</volume>:<fpage>301</fpage>&#8211;<lpage>38</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/bs.mie.2018.01.012</pub-id><pub-id pub-id-type="pmid">29588037</pub-id></mixed-citation></ref><ref id="pone.0316262.ref014"><label>14</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Kitamura</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Marszalec</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Yeh</surname><given-names>JZ</given-names></name>, <name name-style="western"><surname>Narahashi</surname><given-names>T</given-names></name>. <article-title>Effects of halothane and propofol on excitatory and inhibitory synaptic transmission in rat cortical neurons</article-title>. <source>J Pharmacol Exp Ther</source>. <year>2003</year><month>Jan</month>;<volume>304</volume>(<issue>1</issue>):<fpage>162</fpage>&#8211;<lpage>71</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1124/jpet.102.043273</pub-id><pub-id pub-id-type="pmid">12490587</pub-id></mixed-citation></ref><ref id="pone.0316262.ref015"><label>15</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Pittson</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Himmel</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>MacIver</surname><given-names>MB</given-names></name>. <article-title>Multiple synaptic and membrane sites of anesthetic action in the CA1 region of rat hippocampal slices.</article-title><source>BMC Neurosci.</source><year>2004</year><month>Dec</month><day>3</day>;<volume>5</volume>:<fpage>52</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1186/1471-2202-5-52</pub-id><pub-id pub-id-type="pmid">15579203</pub-id><pub-id pub-id-type="pmcid">PMC543467</pub-id></mixed-citation></ref><ref id="pone.0316262.ref016"><label>16</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Yin</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Fu</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Yu</surname><given-names>T</given-names></name>. <article-title>Effects of ketamine on voltage-gated sodium channels in the barrel cortex and the ventral posteromedial nucleus slices of rats</article-title>. <source>Neuroreport</source>. <year>2019</year><month>Dec</month><day>10</day>;<volume>30</volume>(<issue>17</issue>):<fpage>1197</fpage>&#8211;<lpage>204</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1097/WNR.0000000000001344</pub-id><pub-id pub-id-type="pmid">31568204</pub-id><pub-id pub-id-type="pmcid">PMC6855387</pub-id></mixed-citation></ref><ref id="pone.0316262.ref017"><label>17</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Garcia-Rill</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Kezunovic</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Hyde</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Simon</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Beck</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Urbano</surname><given-names>FJ</given-names></name>. <article-title>Coherence and frequency in the reticular activating system (RAS).</article-title><source>Sleep Med Rev.</source><year>2013</year><source>Jun</source>;<volume>17</volume>(<issue>3</issue>):<fpage>227</fpage>&#8211;<lpage>38</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.smrv.2012.06.002</pub-id><pub-id pub-id-type="pmid">23044219</pub-id><pub-id pub-id-type="pmcid">PMC3615556</pub-id></mixed-citation></ref><ref id="pone.0316262.ref018"><label>18</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Moruzzi</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Magoun</surname><given-names>HW</given-names></name>. <article-title>Brain stem reticular formation and activation of the EEG</article-title>. <source>Electroencephalogr Clin Neurophysiol</source>. <year>1949</year><month>Jan</month><day>1</day>;<volume>1</volume>(<issue>1&#8211;4</issue>):<fpage>455</fpage>&#8211;<lpage>73</lpage>. <pub-id pub-id-type="pmid">18421835</pub-id></mixed-citation></ref><ref id="pone.0316262.ref019"><label>19</label><mixed-citation publication-type="book"><name name-style="western"><surname>Posner</surname><given-names>JB</given-names></name>, <name name-style="western"><surname>Saper</surname><given-names>CB</given-names></name>, <name name-style="western"><surname>Schiff</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Plum</surname><given-names>F</given-names></name>. <source>Plum and Posner&#8217;s Diagnosis of Stupor and Coma</source>. <publisher-name>Oxford University Press</publisher-name>; <year>2007</year>. 400 p.</mixed-citation></ref><ref id="pone.0316262.ref020"><label>20</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Timofeev</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Grenier</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Bazhenov</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Sejnowski</surname><given-names>TJ</given-names></name>, <name name-style="western"><surname>Steriade</surname><given-names>M</given-names></name>. <article-title>Origin of slow cortical oscillations in deafferented cortical slabs</article-title>. <source>Cereb Cortex</source>. <year>2000</year><month>Dec</month>;<volume>10</volume>(<issue>12</issue>):<fpage>1185</fpage>&#8211;<lpage>99</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/cercor/10.12.1185</pub-id><pub-id pub-id-type="pmid">11073868</pub-id></mixed-citation></ref><ref id="pone.0316262.ref021"><label>21</label><mixed-citation publication-type="journal"><name name-style="western"><surname>D&#8217;Andola</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Rebollo</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Casali</surname><given-names>AG</given-names></name>, <name name-style="western"><surname>Weinert</surname><given-names>JF</given-names></name>, <name name-style="western"><surname>Pigorini</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Villa</surname><given-names>R</given-names></name>, <etal>et al</etal>. <article-title>Bistability, Causality, and Complexity in Cortical Networks: An In Vitro Perturbational Study</article-title>. <source>Cereb Cortex</source>. <year>2018</year><month>Jul</month><day>1</day>;<volume>28</volume>(<issue>7</issue>):<fpage>2233</fpage>&#8211;<lpage>42</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/cercor/bhx122</pub-id><pub-id pub-id-type="pmid">28525544</pub-id></mixed-citation></ref><ref id="pone.0316262.ref022"><label>22</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Fisahn</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Pike</surname><given-names>FG</given-names></name>, <name name-style="western"><surname>Buhl</surname><given-names>EH</given-names></name>, <name name-style="western"><surname>Paulsen</surname><given-names>O</given-names></name>. <article-title>Cholinergic induction of network oscillations at 40 Hz in the hippocampus in vitro</article-title>. <source>Nature</source>. <year>1998</year><month>Jul</month><day>9</day>;<volume>394</volume>(<issue>6689</issue>):<fpage>186</fpage>&#8211;<lpage>9</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/28179</pub-id><pub-id pub-id-type="pmid">9671302</pub-id></mixed-citation></ref><ref id="pone.0316262.ref023"><label>23</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Whittington</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Traub</surname><given-names>RD</given-names></name>, <name name-style="western"><surname>Jefferys</surname><given-names>JG</given-names></name>. <article-title>Synchronized oscillations in interneuron networks driven by metabotropic glutamate receptor activation</article-title>. <source>Nature</source>. <year>1995</year><month>Feb</month><day>16</day>;<volume>373</volume>(<issue>6515</issue>):<fpage>612</fpage>&#8211;<lpage>5</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/373612a0</pub-id><pub-id pub-id-type="pmid">7854418</pub-id></mixed-citation></ref><ref id="pone.0316262.ref024"><label>24</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Bland</surname><given-names>BH</given-names></name>, <name name-style="western"><surname>Colom</surname><given-names>LV</given-names></name>, <name name-style="western"><surname>Konopacki</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Roth</surname><given-names>SH</given-names></name>. <article-title>Intracellular records of carbachol-induced theta rhythm in hippocampal slices</article-title>. <source>Brain Res</source>. <year>1988</year><month>May</month><day>3</day>;<volume>447</volume>(<issue>2</issue>):<fpage>364</fpage>&#8211;<lpage>8</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/0006-8993(88)91141-9</pub-id><pub-id pub-id-type="pmid">3390706</pub-id></mixed-citation></ref><ref id="pone.0316262.ref025"><label>25</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Lukatch</surname><given-names>HS</given-names></name>, <name name-style="western"><surname>Kiddoo</surname><given-names>CE</given-names></name>, <name name-style="western"><surname>Maciver</surname><given-names>MB</given-names></name>. <article-title>Anesthetic-induced burst suppression EEG activity requires glutamate-mediated excitatory synaptic transmission</article-title>. <source>Cereb Cortex</source>. <year>2005</year><month>Sep</month><day>12</day>;<volume>15</volume>(<issue>9</issue>):<fpage>1322</fpage>&#8211;<lpage>31</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/cercor/bhi015</pub-id><pub-id pub-id-type="pmid">15647528</pub-id></mixed-citation></ref><ref id="pone.0316262.ref026"><label>26</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Lukatch</surname><given-names>HS</given-names></name>, <name name-style="western"><surname>MacIver</surname><given-names>MB</given-names></name>. <article-title>Physiology, pharmacology, and topography of cholinergic neocortical oscillations in vitro</article-title>. <source>J Neurophysiol</source>. <year>1997</year><month>May</month>;<volume>77</volume>(<issue>5</issue>):<fpage>2427</fpage>&#8211;<lpage>45</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1152/jn.1997.77.5.2427</pub-id><pub-id pub-id-type="pmid">9163368</pub-id></mixed-citation></ref><ref id="pone.0316262.ref027"><label>27</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Whittington</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Jefferys</surname><given-names>JG</given-names></name>, <name name-style="western"><surname>Traub</surname><given-names>RD</given-names></name>. <article-title>Effects of intravenous anaesthetic agents on fast inhibitory oscillations in the rat hippocampus in vitro</article-title>. <source>Br J Pharmacol</source>. <year>1996</year><month>Aug</month><day>1</day>;<volume>118</volume>(<issue>8</issue>):<fpage>1977</fpage>&#8211;<lpage>86</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1111/j.1476-5381.1996.tb15633.x</pub-id><pub-id pub-id-type="pmid">8864532</pub-id><pub-id pub-id-type="pmcid">PMC1909911</pub-id></mixed-citation></ref><ref id="pone.0316262.ref028"><label>28</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Dickinson</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Awaiz</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Whittington</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Lieb</surname><given-names>WR</given-names></name>, <name name-style="western"><surname>Franks</surname><given-names>NP</given-names></name>. <article-title>The effects of general anaesthetics on carbachol-evoked gamma oscillations in the rat hippocampus in vitro</article-title>. <source>Neuropharmacology</source>. <year>2003</year><month>Jun</month><day>1</day>;<volume>44</volume>(<issue>7</issue>):<fpage>864</fpage>&#8211;<lpage>72</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/s0028-3908(03)00083-2</pub-id><pub-id pub-id-type="pmid">12726818</pub-id></mixed-citation></ref><ref id="pone.0316262.ref029"><label>29</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Huang</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>XJ</given-names></name>, <name name-style="western"><surname>Huang</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Sun</surname><given-names>EY</given-names></name>, <name name-style="western"><surname>Sun</surname><given-names>M</given-names></name>. <article-title>Ketamine protects gamma oscillations by inhibiting hippocampal LTD.</article-title><source>PLoS One</source>. <year>2016</year><month>Jul</month><day>28</day>;<volume>11</volume>(<issue>7</issue>):<fpage>e0159192</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1371/journal.pone.0159192</pub-id><pub-id pub-id-type="pmid">27467732</pub-id><pub-id pub-id-type="pmcid">PMC4965035</pub-id></mixed-citation></ref><ref id="pone.0316262.ref030"><label>30</label><mixed-citation publication-type="journal"><name name-style="western"><surname>McCormick</surname><given-names>DA</given-names></name>, <name name-style="western"><surname>Prince</surname><given-names>DA</given-names></name>. <article-title>Two types of muscarinic response to acetylcholine in mammalian cortical neurons</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>1985</year><month>Sep</month>;<volume>82</volume>(<issue>18</issue>):<fpage>6344</fpage>&#8211;<lpage>8</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1073/pnas.82.18.6344</pub-id><pub-id pub-id-type="pmid">3862134</pub-id><pub-id pub-id-type="pmcid">PMC391050</pub-id></mixed-citation></ref><ref id="pone.0316262.ref031"><label>31</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Nu&#241;ez</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Dom&#237;nguez</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Bu&#241;o</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Fern&#225;ndez de Sevilla</surname><given-names>D</given-names></name>. <article-title>Cholinergic-mediated response enhancement in barrel cortex layer V pyramidal neurons</article-title>. <source>J Neurophysiol</source>. <year>2012</year><month>Sep</month>;<volume>108</volume>(<issue>6</issue>):<fpage>1656</fpage>&#8211;<lpage>68</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1152/jn.00156.2012</pub-id><pub-id pub-id-type="pmid">22723675</pub-id></mixed-citation></ref><ref id="pone.0316262.ref032"><label>32</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Williams</surname><given-names>SR</given-names></name>, <name name-style="western"><surname>Fletcher</surname><given-names>LN</given-names></name>. <article-title>A Dendritic Substrate for the Cholinergic Control of Neocortical Output Neurons</article-title>. <source>Neuron</source>. <year>2019</year><month>Feb</month><day>6</day>;<volume>101</volume>(<issue>3</issue>):<fpage>486</fpage>&#8211;<lpage>99</lpage>.e4. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.neuron.2018.11.035</pub-id><pub-id pub-id-type="pmid">30594427</pub-id></mixed-citation></ref><ref id="pone.0316262.ref033"><label>33</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Hagger-Vaughan</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Kolnier</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Storm</surname><given-names>JF</given-names></name>. <article-title>Non-apical plateau potentials and persistent firing induced by metabotropic cholinergic modulation in layer 2/3 pyramidal cells in the rat prefrontal cortex.</article-title><source>PLoS One.</source><year>2024</year><month>Dec</month><day>10</day>;<volume>19</volume>(<issue>12</issue>):<fpage>e0314652</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1371/journal.pone.0314652</pub-id><pub-id pub-id-type="pmid">39656720</pub-id><pub-id pub-id-type="pmcid">PMC11630621</pub-id></mixed-citation></ref><ref id="pone.0316262.ref034"><label>34</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Mashour</surname><given-names>GA</given-names></name>, <name name-style="western"><surname>Roelfsema</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Changeux</surname><given-names>JP</given-names></name>, <name name-style="western"><surname>Dehaene</surname><given-names>S</given-names></name>. <article-title>Conscious Processing and the Global Neuronal Workspace Hypothesis</article-title>. <source>Neuron</source>. <year>2020</year><month>Mar</month><day>4</day>;<volume>105</volume>(<issue>5</issue>):<fpage>776</fpage>&#8211;<lpage>98</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.neuron.2020.01.026</pub-id><pub-id pub-id-type="pmid">32135090</pub-id><pub-id pub-id-type="pmcid">PMC8770991</pub-id></mixed-citation></ref><ref id="pone.0316262.ref035"><label>35</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Nordstr&#246;m</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Engstr&#246;m</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>Persson</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Sandin</surname><given-names>R</given-names></name>. <article-title>Incidence of awareness in total i.v. anaesthesia based on propofol, alfentanil and neuromuscular blockade.</article-title><source>Acta Anaesthesiol Scand.</source><year>1997</year><source>Sep</source>;<volume>41</volume>(<issue>8</issue>):<fpage>978</fpage>&#8211;<lpage>84</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1111/j.1399-6576.1997.tb04823.x</pub-id><pub-id pub-id-type="pmid">9311394</pub-id></mixed-citation></ref><ref id="pone.0316262.ref036"><label>36</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Nilsen</surname><given-names>AS</given-names></name>, <name name-style="western"><surname>Arena</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Storm</surname><given-names>JF</given-names></name>. <article-title>Exploring effects of anesthesia on complexity, differentiation, and integrated information in rat EEG.</article-title><source>Neurosci Conscious.</source><year>2024</year><month>May</month><day>16</day>;<volume>2024</volume>(<issue>1</issue>):<fpage>niae021</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/nc/niae021</pub-id><pub-id pub-id-type="pmid">38757120</pub-id><pub-id pub-id-type="pmcid">PMC11097907</pub-id></mixed-citation></ref><ref id="pone.0316262.ref037"><label>37</label><mixed-citation publication-type="book"><name name-style="western"><surname>Edwards</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Preuss</surname><given-names>CV</given-names></name>. <part-title>GABA Receptor Positive Allosteric Modulators.</part-title> In: <source>StatPearls</source>. <publisher-loc>Treasure Island (FL)</publisher-loc>: <publisher-name>StatPearls Publishing</publisher-name>; <year>2023</year>.<pub-id pub-id-type="pmid">32119330</pub-id></mixed-citation></ref><ref id="pone.0316262.ref038"><label>38</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Trapani</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Altomare</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Liso</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Sanna</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Biggio</surname><given-names>G</given-names></name>. <article-title>Propofol in anesthesia. Mechanism of action, structure-activity relationships, and drug delivery</article-title>. <source>Curr Med Chem</source>. <year>2000</year><month>Feb</month>;<volume>7</volume>(<issue>2</issue>):<fpage>249</fpage>&#8211;<lpage>71</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.2174/0929867003375335</pub-id><pub-id pub-id-type="pmid">10637364</pub-id></mixed-citation></ref><ref id="pone.0316262.ref039"><label>39</label><mixed-citation publication-type="journal"><name name-style="western"><surname>McMillan</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Muthukumaraswamy</surname><given-names>SD</given-names></name>. <article-title>The neurophysiology of ketamine: an integrative review.</article-title><source>Rev Neurosci.</source><year>2020</year><month>Jul</month><day>28</day>;<volume>31</volume>(<issue>5</issue>):<fpage>457</fpage>&#8211;<lpage>503</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1515/revneuro-2019-0090</pub-id><pub-id pub-id-type="pmid">32374293</pub-id></mixed-citation></ref><ref id="pone.0316262.ref040"><label>40</label><mixed-citation publication-type="book"><name name-style="western"><surname>Hofschneider</surname><given-names>M.</given-names></name><source>Discovery and development of propofol, a widely used anesthetic [Internet].</source><publisher-name>Lasker Foundation</publisher-name>. <year>2018</year> [cited 2023 Oct 10]. Available from: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://laskerfoundation.org/winners/discovery-and-development-of-propofol-a-widely-used-anesthetic/" ext-link-type="uri">https://laskerfoundation.org/winners/discovery-and-development-of-propofol-a-widely-used-anesthetic/</ext-link></mixed-citation></ref><ref id="pone.0316262.ref041"><label>41</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Ying</surname><given-names>SW</given-names></name>, <name name-style="western"><surname>Abbas</surname><given-names>SY</given-names></name>, <name name-style="western"><surname>Harrison</surname><given-names>NL</given-names></name>, <name name-style="western"><surname>Goldstein</surname><given-names>PA</given-names></name>. Propofol block of I(h) <article-title>contributes to the suppression of neuronal excitability and rhythmic burst firing in thalamocortical neurons</article-title>. <source>Eur J Neurosci</source>. <year>2006</year><month>Jan</month>;<volume>23</volume>(<issue>2</issue>):<fpage>465</fpage>&#8211;<lpage>80</lpage>.<pub-id pub-id-type="pmid">16420453</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1460-9568.2005.04587.x</pub-id></mixed-citation></ref><ref id="pone.0316262.ref042"><label>42</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Ying</surname><given-names>SW</given-names></name>, <name name-style="western"><surname>Goldstein</surname><given-names>PA</given-names></name>. <article-title>Propofol-block of SK channels in reticular thalamic neurons enhances GABAergic inhibition in relay neurons</article-title>. <source>J Neurophysiol</source>. <year>2005</year><month>Apr</month>;<volume>93</volume>(<issue>4</issue>):<fpage>1935</fpage>&#8211;<lpage>48</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1152/jn.01058.2004</pub-id><pub-id pub-id-type="pmid">15563549</pub-id></mixed-citation></ref><ref id="pone.0316262.ref043"><label>43</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Fassl</surname><given-names>J</given-names></name>, <name name-style="western"><surname>High</surname><given-names>KM</given-names></name>, <name name-style="western"><surname>Stephenson</surname><given-names>ER</given-names></name>, <name name-style="western"><surname>Yarotskyy</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Elmslie</surname><given-names>KS</given-names></name>. <article-title>The intravenous anesthetic propofol inhibits human L-type calcium channels by enhancing voltage-dependent inactivation</article-title>. <source>J Clin Pharmacol</source>. <year>2011</year><month>May</month>;<volume>51</volume>(<issue>5</issue>):<fpage>719</fpage>&#8211;<lpage>30</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1177/0091270010373098</pub-id><pub-id pub-id-type="pmid">20547772</pub-id></mixed-citation></ref><ref id="pone.0316262.ref044"><label>44</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Bahnasi</surname><given-names>YM</given-names></name>, <name name-style="western"><surname>Wright</surname><given-names>HM</given-names></name>, <name name-style="western"><surname>Milligan</surname><given-names>CJ</given-names></name>, <name name-style="western"><surname>Dedman</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>Zeng</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Hopkins</surname><given-names>PM</given-names></name>, <etal>et al</etal>. <article-title>Modulation of TRPC5 cation channels by halothane, chloroform and propofol</article-title>. <source>Br J Pharmacol</source>. <year>2008</year><month>Apr</month>;<volume>153</volume>(<issue>7</issue>):<fpage>1505</fpage>&#8211;<lpage>12</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/sj.bjp.0707689</pub-id><pub-id pub-id-type="pmid">18204473</pub-id><pub-id pub-id-type="pmcid">PMC2437913</pub-id></mixed-citation></ref><ref id="pone.0316262.ref045"><label>45</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Kurdi</surname><given-names>MS</given-names></name>, <name name-style="western"><surname>Theerth</surname><given-names>KA</given-names></name>, <name name-style="western"><surname>Deva</surname><given-names>RS</given-names></name>. <article-title>Ketamine: Current applications in anesthesia, pain, and critical care.</article-title><source>Anesth Essays Res.</source><year>2014</year><month>Sep-Dec</month>;<volume>8</volume>(<issue>3</issue>):<fpage>283</fpage>&#8211;<lpage>90</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.4103/0259-1162.143110</pub-id><pub-id pub-id-type="pmid">25886322</pub-id><pub-id pub-id-type="pmcid">PMC4258981</pub-id></mixed-citation></ref><ref id="pone.0316262.ref046"><label>46</label><mixed-citation publication-type="journal"><name name-style="western"><surname>White</surname><given-names>PF</given-names></name>, <name name-style="western"><surname>Way</surname><given-names>WL</given-names></name>, <name name-style="western"><surname>Trevor</surname><given-names>AJ</given-names></name>. <article-title>Ketamine&#8212;its pharmacology and therapeutic uses</article-title>. <source>Anesthesiology</source>. <year>1982</year><month>Feb</month>;<volume>56</volume>(<issue>2</issue>):<fpage>119</fpage>&#8211;<lpage>36</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1097/00000542-198202000-00007</pub-id><pub-id pub-id-type="pmid">6892475</pub-id></mixed-citation></ref><ref id="pone.0316262.ref047"><label>47</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Lydic</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Baghdoyan</surname><given-names>HA</given-names></name>. <article-title>Ketamine and MK-801 decrease acetylcholine release in the pontine reticular formation, slow breathing, and disrupt sleep.</article-title><source>Sleep.</source><year>2002</year><month>Sep</month><day>15</day>;<volume>25</volume>(<issue>6</issue>):<fpage>617</fpage>&#8211;<lpage>22</lpage>. <pub-id pub-id-type="pmid">12224840</pub-id></mixed-citation></ref><ref id="pone.0316262.ref048"><label>48</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Chen</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Shu</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Bayliss</surname><given-names>DA</given-names></name>. <article-title>HCN1 channel subunits are a molecular substrate for hypnotic actions of ketamine</article-title>. <source>J Neurosci</source>. <year>2009</year><month>Jan</month><day>21</day>;<volume>29</volume>(<issue>3</issue>):<fpage>600</fpage>&#8211;<lpage>9</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1523/JNEUROSCI.3481-08.2009</pub-id><pub-id pub-id-type="pmid">19158287</pub-id><pub-id pub-id-type="pmcid">PMC2744993</pub-id></mixed-citation></ref><ref id="pone.0316262.ref049"><label>49</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Yamakage</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Hirshman</surname><given-names>CA</given-names></name>, <name name-style="western"><surname>Croxton</surname><given-names>TL</given-names></name>. <article-title>Inhibitory Effects of Thiopental, Ketamine, and Propofol on Voltage-dependent Calcium sup 2+ Channels in Porcine Tracheal Smooth Muscle Cells</article-title>. <source>Anesthesiology</source>. <year>1995</year><month>Dec</month><day>1</day>;<volume>83</volume>(<issue>6</issue>):<fpage>1274</fpage>&#8211;<lpage>82</lpage>.<pub-id pub-id-type="pmid">8533920</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/00000542-199512000-00018</pub-id></mixed-citation></ref><ref id="pone.0316262.ref050"><label>50</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Moliner</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Girych</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Brunello</surname><given-names>CA</given-names></name>, <name name-style="western"><surname>Kovaleva</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Biojone</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Enkavi</surname><given-names>G</given-names></name>, <etal>et al</etal>. <article-title>Psychedelics promote plasticity by directly binding to BDNF receptor TrkB</article-title>. <source>Nat Neurosci</source>. <year>2023</year><month>Jun</month>;<volume>26</volume>(<issue>6</issue>):<fpage>1032</fpage>&#8211;<lpage>41</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/s41593-023-01316-5</pub-id><pub-id pub-id-type="pmid">37280397</pub-id><pub-id pub-id-type="pmcid">PMC10244169</pub-id></mixed-citation></ref><ref id="pone.0316262.ref051"><label>51</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Casali</surname><given-names>AG</given-names></name>, <name name-style="western"><surname>Gosseries</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Rosanova</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Boly</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Sarasso</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Casali</surname><given-names>KR</given-names></name>, <etal>et al</etal>. <article-title>A theoretically based index of consciousness independent of sensory processing and behavior.</article-title><source>Sci Transl Med.</source><year>2013</year><month>Aug</month><day>14</day>;<volume>5</volume>(<issue>198</issue>):198ra105. <comment>doi: </comment><pub-id pub-id-type="doi">10.1126/scitranslmed.3006294</pub-id><pub-id pub-id-type="pmid">23946194</pub-id></mixed-citation></ref><ref id="pone.0316262.ref052"><label>52</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Casey</surname><given-names>CP</given-names></name>, <name name-style="western"><surname>Tanabe</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Farahbakhsh</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Parker</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Bo</surname><given-names>A</given-names></name>, <name name-style="western"><surname>White</surname><given-names>M</given-names></name>, <etal>et al</etal>. <article-title>Distinct EEG signatures differentiate unconsciousness and disconnection during anaesthesia and sleep</article-title>. <source>Br J Anaesth</source>. <year>2022</year><month>Jun</month>;<volume>128</volume>(<issue>6</issue>):<fpage>1006</fpage>&#8211;<lpage>18</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.bja.2022.01.010</pub-id><pub-id pub-id-type="pmid">35148892</pub-id><pub-id pub-id-type="pmcid">PMC9428919</pub-id></mixed-citation></ref><ref id="pone.0316262.ref053"><label>53</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Colombo</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Napolitani</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Boly</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Gosseries</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Casarotto</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Rosanova</surname><given-names>M</given-names></name>, <etal>et al</etal>. <article-title>The spectral exponent of the resting EEG indexes the presence of consciousness during unresponsiveness induced by propofol, xenon, and ketamine.</article-title><source>Neuroimage.</source><year>2019</year><month>Apr</month><day>1</day>;<volume>189</volume>:<fpage>631</fpage>&#8211;<lpage>44</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.neuroimage.2019.01.024</pub-id><pub-id pub-id-type="pmid">30639334</pub-id></mixed-citation></ref><ref id="pone.0316262.ref054"><label>54</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Aru</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Siclari</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Phillips</surname><given-names>WA</given-names></name>, <name name-style="western"><surname>Storm</surname><given-names>JF</given-names></name>. <article-title>Apical drive-A cellular mechanism of dreaming?</article-title><source>Neurosci Biobehav Rev.</source><year>2020</year><month>Dec</month>;<volume>119</volume>:<fpage>440</fpage>&#8211;<lpage>55</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.neubiorev.2020.09.018</pub-id><pub-id pub-id-type="pmid">33002561</pub-id></mixed-citation></ref><ref id="pone.0316262.ref055"><label>55</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Hobson</surname><given-names>JA</given-names></name>. <article-title>REM sleep and dreaming: towards a theory of protoconsciousness.</article-title><source>Nat Rev Neurosci.</source><year>2009</year><month>Nov</month>;<volume>10</volume>(<issue>11</issue>):<fpage>803</fpage>&#8211;<lpage>13</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/nrn2716</pub-id><pub-id pub-id-type="pmid">19794431</pub-id></mixed-citation></ref><ref id="pone.0316262.ref056"><label>56</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Boly</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Massimini</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Tsuchiya</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Postle</surname><given-names>BR</given-names></name>, <name name-style="western"><surname>Koch</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Tononi</surname><given-names>G</given-names></name>. <article-title>Are the Neural Correlates of Consciousness in the Front or in the Back of the Cerebral Cortex? Clinical and Neuroimaging Evidence</article-title>. <source>J Neurosci</source>. <year>2017</year><month>Oct</month><day>4</day>;<volume>37</volume>(<issue>40</issue>):<fpage>9603</fpage>&#8211;<lpage>13</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1523/JNEUROSCI.3218-16.2017</pub-id><pub-id pub-id-type="pmid">28978697</pub-id><pub-id pub-id-type="pmcid">PMC5628406</pub-id></mixed-citation></ref><ref id="pone.0316262.ref057"><label>57</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Brown</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Lau</surname><given-names>H</given-names></name>, <name name-style="western"><surname>LeDoux</surname><given-names>JE</given-names></name>. <article-title>Understanding the Higher-Order Approach to Consciousness.</article-title><source>Trends Cogn Sci.</source><year>2019</year><month>Sep</month><day>1</day>;<volume>23</volume>(<issue>9</issue>):<fpage>754</fpage>&#8211;<lpage>68</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.tics.2019.06.009</pub-id><pub-id pub-id-type="pmid">31375408</pub-id></mixed-citation></ref><ref id="pone.0316262.ref058"><label>58</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Moore</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Armstrong</surname><given-names>KM</given-names></name>. <article-title>Selective gating of visual signals by microstimulation of frontal cortex</article-title>. <source>Nature</source>. <year>2003</year><month>Jan</month><day>23</day>;<volume>421</volume>(<issue>6921</issue>):<fpage>370</fpage>&#8211;<lpage>3</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/nature01341</pub-id><pub-id pub-id-type="pmid">12540901</pub-id></mixed-citation></ref><ref id="pone.0316262.ref059"><label>59</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Clark</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Squire</surname><given-names>RF</given-names></name>, <name name-style="western"><surname>Merrikhi</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Noudoost</surname><given-names>B</given-names></name>. <article-title>Visual attention: Linking prefrontal sources to neuronal and behavioral correlates</article-title>. <source>Prog Neurobiol</source>. <year>2015</year><month>Sep</month>;<volume>132</volume>:<fpage>59</fpage>&#8211;<lpage>80</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.pneurobio.2015.06.006</pub-id><pub-id pub-id-type="pmid">26159708</pub-id></mixed-citation></ref><ref id="pone.0316262.ref060"><label>60</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Asaad</surname><given-names>WF</given-names></name>, <name name-style="western"><surname>Rainer</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Miller</surname><given-names>EK</given-names></name>. <article-title>Neural Activity in the Primate Prefrontal Cortex during Associative Learning</article-title>. <source>Neuron</source>. <year>1998</year><month>Dec</month><day>1</day>;<volume>21</volume>(<issue>6</issue>):<fpage>1399</fpage>&#8211;<lpage>407</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/s0896-6273(00)80658-3</pub-id><pub-id pub-id-type="pmid">9883732</pub-id></mixed-citation></ref><ref id="pone.0316262.ref061"><label>61</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Burgos-Robles</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Kimchi</surname><given-names>EY</given-names></name>, <name name-style="western"><surname>Izadmehr</surname><given-names>EM</given-names></name>, <name name-style="western"><surname>Porzenheim</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Ramos-Guasp</surname><given-names>WA</given-names></name>, <name name-style="western"><surname>Nieh</surname><given-names>EH</given-names></name>, <etal>et al</etal>. <article-title>Amygdala inputs to prefrontal cortex guide behavior amid conflicting cues of reward and punishment</article-title>. <source>Nat Neurosci</source>. <year>2017</year><month>Jun</month>;<volume>20</volume>(<issue>6</issue>):<fpage>824</fpage>&#8211;<lpage>35</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/nn.4553</pub-id><pub-id pub-id-type="pmid">28436980</pub-id><pub-id pub-id-type="pmcid">PMC5448704</pub-id></mixed-citation></ref><ref id="pone.0316262.ref062"><label>62</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Wang</surname><given-names>XJ</given-names></name>. <article-title>Synaptic reverberation underlying mnemonic persistent activity</article-title>. <source>Trends Neurosci</source>. <year>2001</year><month>Aug</month><day>1</day>;<volume>24</volume>(<issue>8</issue>):<fpage>455</fpage>&#8211;<lpage>63</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/s0166-2236(00)01868-3</pub-id><pub-id pub-id-type="pmid">11476885</pub-id></mixed-citation></ref><ref id="pone.0316262.ref063"><label>63</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Dehaene</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Kerszberg</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Changeux</surname><given-names>JP</given-names></name>. <article-title>A neuronal model of a global workspace in effortful cognitive tasks</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>1998</year><month>Nov</month><day>24</day>;<volume>95</volume>(<issue>24</issue>):<fpage>14529</fpage>&#8211;<lpage>34</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1073/pnas.95.24.14529</pub-id><pub-id pub-id-type="pmid">9826734</pub-id><pub-id pub-id-type="pmcid">PMC24407</pub-id></mixed-citation></ref><ref id="pone.0316262.ref064"><label>64</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Goldman-Rakic</surname><given-names>PS</given-names></name>. <article-title>Topography of cognition: parallel distributed networks in primate association cortex</article-title>. <source>Annu Rev Neurosci</source>. <year>1988</year>;<volume>11</volume>:<fpage>137</fpage>&#8211;<lpage>56</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1146/annurev.ne.11.030188.001033</pub-id><pub-id pub-id-type="pmid">3284439</pub-id></mixed-citation></ref><ref id="pone.0316262.ref065"><label>65</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Paus</surname><given-names>T.</given-names></name><article-title>Functional anatomy of arousal and attention systems in the human brain.</article-title><year>2000</year><month>Jan</month><day>1</day>;<volume>126</volume>:<fpage>65</fpage>&#8211;<lpage>77</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/S0079-6123(00)26007-X</pub-id><pub-id pub-id-type="pmid">11105640</pub-id></mixed-citation></ref><ref id="pone.0316262.ref066"><label>66</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Steriade</surname></name>, <name name-style="western"><surname>Timofeev</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Grenier</surname><given-names>F</given-names></name>. <article-title>Natural Waking and Sleep States: A View From Inside Neocortical Neurons.</article-title><source>J Neurophysiol</source> [Internet]. <year>2001</year><month>May</month><day>1</day> [cited 2023 Aug 1]; Available from: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://journals.physiology.org/doi/10.1152/jn.2001.85.5.1969" ext-link-type="uri">https://journals.physiology.org/doi/10.1152/jn.2001.85.5.1969</ext-link><pub-id pub-id-type="doi" assigning-authority="pmc">10.1152/jn.2001.85.5.1969</pub-id><pub-id pub-id-type="pmid">11353014</pub-id></mixed-citation></ref><ref id="pone.0316262.ref067"><label>67</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Watson</surname><given-names>CJ</given-names></name>, <name name-style="western"><surname>Baghdoyan</surname><given-names>HA</given-names></name>, <name name-style="western"><surname>Lydic</surname><given-names>R</given-names></name>. <article-title>Neuropharmacology of Sleep and Wakefulness.</article-title><source>Sleep Med Clin</source>. <year>2010</year><month>Dec</month>;<volume>5</volume>(<issue>4</issue>):<fpage>513</fpage>&#8211;<lpage>28</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.jsmc.2010.08.003</pub-id><pub-id pub-id-type="pmid">21278831</pub-id><pub-id pub-id-type="pmcid">PMC3026477</pub-id></mixed-citation></ref><ref id="pone.0316262.ref068"><label>68</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Lee</surname><given-names>MG</given-names></name>, <name name-style="western"><surname>Hassani</surname><given-names>OK</given-names></name>, <name name-style="western"><surname>Alonso</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Jones</surname><given-names>BE</given-names></name>. <article-title>Cholinergic basal forebrain neurons burst with theta during waking and paradoxical sleep</article-title>. <source>J Neurosci</source>. <year>2005</year><month>Apr</month><day>27</day>;<volume>25</volume>(<issue>17</issue>):<fpage>4365</fpage>&#8211;<lpage>9</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1523/JNEUROSCI.0178-05.2005</pub-id><pub-id pub-id-type="pmid">15858062</pub-id><pub-id pub-id-type="pmcid">PMC6725118</pub-id></mixed-citation></ref><ref id="pone.0316262.ref069"><label>69</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Edlow</surname><given-names>BL</given-names></name>, <name name-style="western"><surname>Claassen</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Schiff</surname><given-names>ND</given-names></name>, <name name-style="western"><surname>Greer</surname><given-names>DM</given-names></name>. <article-title>Recovery from disorders of consciousness: mechanisms, prognosis and emerging therapies.</article-title><source>Nat Rev Neurol.</source><year>2020</year><month>Dec</month><day>14</day>;<volume>17</volume>(<issue>3</issue>):<fpage>135</fpage>&#8211;<lpage>56</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/s41582-020-00428-x</pub-id><pub-id pub-id-type="pmid">33318675</pub-id><pub-id pub-id-type="pmcid">PMC7734616</pub-id></mixed-citation></ref><ref id="pone.0316262.ref070"><label>70</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Dasilva</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Camassa</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Navarro-Guzman</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Pazienti</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Perez-Mendez</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Zamora-L&#243;pez</surname><given-names>G</given-names></name>, <etal>et al</etal>. <article-title>Modulation of cortical slow oscillations and complexity across anesthesia levels.</article-title><source>Neuroimage</source>. <year>2021</year><month>Jan</month><day>1</day>;<volume>224</volume>:<fpage>117415</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.neuroimage.2020.117415</pub-id><pub-id pub-id-type="pmid">33011419</pub-id></mixed-citation></ref><ref id="pone.0316262.ref071"><label>71</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Cole</surname><given-names>AE</given-names></name>, <name name-style="western"><surname>Nicoll</surname><given-names>RA</given-names></name>. <article-title>Characterization of a slow cholinergic post-synaptic potential recorded in vitro from rat hippocampal pyramidal cells</article-title>. <source>J Physiol</source> [Internet]. <year>1984</year><month>Jul</month> [cited 2023 Nov 30];<volume>352</volume>. Available from: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/6747887/" ext-link-type="uri">https://pubmed.ncbi.nlm.nih.gov/6747887/</ext-link><comment>doi: </comment><pub-id pub-id-type="doi">10.1113/jphysiol.1984.sp015285</pub-id><pub-id pub-id-type="pmid">6747887</pub-id><pub-id pub-id-type="pmcid">PMC1193205</pub-id></mixed-citation></ref><ref id="pone.0316262.ref072"><label>72</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Fraser</surname><given-names>DD</given-names></name>, <name name-style="western"><surname>MacVicar</surname><given-names>BA</given-names></name>. <article-title>Cholinergic-dependent plateau potential in hippocampal CA1 pyramidal neurons</article-title>. <source>J Neurosci</source>. <year>1996</year><month>Jul</month><day>1</day>;<volume>16</volume>(<issue>13</issue>):<fpage>4113</fpage>&#8211;<lpage>28</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1523/JNEUROSCI.16-13-04113.1996</pub-id><pub-id pub-id-type="pmid">8753873</pub-id><pub-id pub-id-type="pmcid">PMC6578995</pub-id></mixed-citation></ref><ref id="pone.0316262.ref073"><label>73</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Egorov</surname><given-names>AV</given-names></name>, <name name-style="western"><surname>Hamam</surname><given-names>BN</given-names></name>, <name name-style="western"><surname>Frans&#233;n</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Hasselmo</surname><given-names>ME</given-names></name>, <name name-style="western"><surname>Alonso</surname><given-names>AA</given-names></name>. <article-title>Graded persistent activity in entorhinal cortex neurons</article-title>. <source>Nature</source>. <year>2002</year><month>Nov</month>;<volume>420</volume>(<issue>6912</issue>):<fpage>173</fpage>&#8211;<lpage>8</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/nature01171</pub-id><pub-id pub-id-type="pmid">12432392</pub-id></mixed-citation></ref><ref id="pone.0316262.ref074"><label>74</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Valero-Aracama</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Reboreda</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Arboit</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Sauvage</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Yoshida</surname><given-names>M</given-names></name>. <article-title>Noradrenergic suppression of persistent firing in hippocampal CA1 pyramidal cells through cAMP-PKA pathway.</article-title><source>eNeuro. 2021</source><month>Mar</month>;<volume>8</volume>(<issue>2</issue>):ENEURO.0440&#8211;20.<year>2020</year>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1523/ENEURO.0440-20.2020</pub-id><pub-id pub-id-type="pmcid">PMC8009666</pub-id><pub-id pub-id-type="pmid">33637539</pub-id></mixed-citation></ref><ref id="pone.0316262.ref075"><label>75</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Zhang</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Reboreda</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Alonso</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Barker</surname><given-names>PA</given-names></name>, <name name-style="western"><surname>S&#233;gu&#233;la</surname><given-names>P</given-names></name>. <article-title>TRPC channels underlie cholinergic plateau potentials and persistent activity in entorhinal cortex.</article-title><source>Hippocampus.</source><year>2011</year><month>Apr</month>;<volume>21</volume>(<issue>4</issue>):<fpage>386</fpage>&#8211;<lpage>97</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1002/hipo.20755</pub-id><pub-id pub-id-type="pmid">20082292</pub-id></mixed-citation></ref><ref id="pone.0316262.ref076"><label>76</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Knauer</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Jochems</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Valero-Aracama</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Yoshida</surname><given-names>M</given-names></name>. <article-title>Long-lasting intrinsic persistent firing in rat CA1 pyramidal cells: a possible mechanism for active maintenance of memory: Long-Lasting Persistent Firing in Ca1 Pyramidal Cells.</article-title><source>Hippocampus.</source><year>2013</year><month>Sep</month>;<volume>23</volume>(<issue>9</issue>):<fpage>820</fpage>&#8211;<lpage>31</lpage>.<pub-id pub-id-type="pmid">23609880</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/hipo.22136</pub-id></mixed-citation></ref><ref id="pone.0316262.ref077"><label>77</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Yan</surname><given-names>HD</given-names></name>, <name name-style="western"><surname>Villalobos</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Andrade</surname><given-names>R</given-names></name>. <article-title>TRPC channels mediate a muscarinic receptor-induced afterdepolarization in cerebral cortex</article-title>. <source>J Neurosci</source>. <year>2009</year><month>Aug</month><day>12</day>;<volume>29</volume>(<issue>32</issue>):<fpage>10038</fpage>&#8211;<lpage>46</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1523/JNEUROSCI.1042-09.2009</pub-id><pub-id pub-id-type="pmid">19675237</pub-id><pub-id pub-id-type="pmcid">PMC2747319</pub-id></mixed-citation></ref><ref id="pone.0316262.ref078"><label>78</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Jochems</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Yoshida</surname><given-names>M</given-names></name>. <article-title>Persistent firing supported by an intrinsic cellular mechanism in hippocampal CA3 pyramidal cells</article-title>. <source>Eur J Neurosci</source>. <year>2013</year><month>Jul</month>;<volume>38</volume>(<issue>2</issue>):<fpage>2250</fpage>&#8211;<lpage>9</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1111/ejn.12236</pub-id><pub-id pub-id-type="pmid">23651161</pub-id></mixed-citation></ref><ref id="pone.0316262.ref079"><label>79</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Haj-Dahmane</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Andrade</surname><given-names>R</given-names></name>. <article-title>Ionic mechanism of the slow afterdepolarization induced by muscarinic receptor activation in rat prefrontal cortex</article-title>. <source>J Neurophysiol</source>. <year>1998</year><month>Sep</month>;<volume>80</volume>(<issue>3</issue>):<fpage>1197</fpage>&#8211;<lpage>210</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1152/jn.1998.80.3.1197</pub-id><pub-id pub-id-type="pmid">9744932</pub-id></mixed-citation></ref><ref id="pone.0316262.ref080"><label>80</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Gambino</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Pag&#232;s</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Kehayas</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Baptista</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Tatti</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Carleton</surname><given-names>A</given-names></name>, <etal>et al</etal>. <article-title>Sensory-evoked LTP driven by dendritic plateau potentials in vivo</article-title>. <source>Nature</source>. <year>2014</year><month>Aug</month><day>31</day>;<volume>515</volume>(<issue>7525</issue>):<fpage>116</fpage>&#8211;<lpage>9</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/nature13664</pub-id><pub-id pub-id-type="pmid">25174710</pub-id></mixed-citation></ref><ref id="pone.0316262.ref081"><label>81</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Bliss</surname><given-names>TVP</given-names></name>, <name name-style="western"><surname>Collingridge</surname><given-names>GL</given-names></name>. <article-title>A synaptic model of memory: long-term potentiation in the hippocampus</article-title>. <source>Nature</source>. <year>1993</year><month>Jan</month>;<volume>361</volume>(<issue>6407</issue>):<fpage>31</fpage>&#8211;<lpage>9</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/361031a0</pub-id><pub-id pub-id-type="pmid">8421494</pub-id></mixed-citation></ref><ref id="pone.0316262.ref082"><label>82</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Aru</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Suzuki</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Larkum</surname><given-names>ME</given-names></name>. <article-title>Cellular Mechanisms of Conscious Processing: (Trends in Cognitive Sciences, 24, 814&#8211;825; 2020).</article-title><source>Trends Cogn Sci.</source><year>2021</year><month>Dec</month>;<volume>25</volume>(<issue>12</issue>):<fpage>1096</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.tics.2021.09.008</pub-id><pub-id pub-id-type="pmid">34657794</pub-id></mixed-citation></ref><ref id="pone.0316262.ref083"><label>83</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Hagger-Vaughan</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Storm</surname><given-names>JF</given-names></name>. <article-title>Synergy of Glutamatergic and Cholinergic Modulation Induces Plateau Potentials in Hippocampal OLM Interneurons.</article-title><source>Front Cell Neurosci</source>. <year>2019</year><month>Nov</month><day>12</day>;<volume>13</volume>:<fpage>508</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.3389/fncel.2019.00508</pub-id><pub-id pub-id-type="pmid">31780902</pub-id><pub-id pub-id-type="pmcid">PMC6861217</pub-id></mixed-citation></ref><ref id="pone.0316262.ref084"><label>84</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Lo</surname><given-names>FS</given-names></name>, <name name-style="western"><surname>Erzurumlu</surname><given-names>RS</given-names></name>. <article-title>L-type calcium channel-mediated plateau potentials in barrelette cells during structural plasticity</article-title>. <source>J Neurophysiol</source>. <year>2002</year><month>Aug</month>;<volume>88</volume>(<issue>2</issue>):<fpage>794</fpage>&#8211;<lpage>801</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1152/jn.2002.88.2.794</pub-id><pub-id pub-id-type="pmid">12163531</pub-id><pub-id pub-id-type="pmcid">PMC3686508</pub-id></mixed-citation></ref><ref id="pone.0316262.ref085"><label>85</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Oikonomou</surname><given-names>KD</given-names></name>, <name name-style="western"><surname>Singh</surname><given-names>MB</given-names></name>, <name name-style="western"><surname>Sterjanaj</surname><given-names>EV</given-names></name>, <name name-style="western"><surname>Antic</surname><given-names>SD</given-names></name>. <article-title>Spiny neurons of amygdala, striatum, and cortex use dendritic plateau potentials to detect network</article-title><source>UP states. Front Cell Neurosci</source>. <year>2014</year><month>Sep</month><day>17</day>;<volume>8</volume>:<fpage>292</fpage>.<pub-id pub-id-type="pmid">25278841</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fncel.2014.00292</pub-id><pub-id pub-id-type="pmcid">PMC4166350</pub-id></mixed-citation></ref><ref id="pone.0316262.ref086"><label>86</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Maurer</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Lorenz</surname><given-names>DJ</given-names></name>, <name name-style="western"><surname>Pielsticker</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Volk</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Sessler</surname><given-names>DI</given-names></name>, <name name-style="western"><surname>Baumbach</surname><given-names>JI</given-names></name>, <etal>et al</etal>. <article-title>Adherence of volatile propofol to various types of plastic tubing.</article-title><source>J Breath Res.</source><year>2017</year><month>Jan</month><day>23</day>;<volume>11</volume>(<issue>1</issue>):<fpage>016009</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1088/1752-7163/aa567e</pub-id><pub-id pub-id-type="pmid">28049865</pub-id></mixed-citation></ref><ref id="pone.0316262.ref087"><label>87</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Gredell</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Turnquist</surname><given-names>PA</given-names></name>, <name name-style="western"><surname>Maciver</surname><given-names>MB</given-names></name>, <name name-style="western"><surname>Pearce</surname><given-names>RA</given-names></name>. <article-title>Determination of diffusion and partition coefficients of propofol in rat brain tissue: implications for studies of drug action in vitro</article-title>. <source>Br J Anaesth</source>. <year>2004</year><month>Dec</month>;<volume>93</volume>(<issue>6</issue>):<fpage>810</fpage>&#8211;<lpage>7</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/bja/aeh272</pub-id><pub-id pub-id-type="pmid">15377586</pub-id></mixed-citation></ref><ref id="pone.0316262.ref088"><label>88</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Geiger</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>VanVeller</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Lopez</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Harrata</surname><given-names>AK</given-names></name>, <name name-style="western"><surname>Battani</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Wegman-Points</surname><given-names>L</given-names></name>, <etal>et al</etal>. <article-title>Determination of Diffusion Kinetics of Ketamine in Brain Tissue: Implications for in vitro Mechanistic Studies of Drug Actions [Internet].</article-title> Vol. <volume>15</volume>, <source>Frontiers in Neuroscience</source>. <year>2021</year>. Available from: <pub-id pub-id-type="doi">10.3389/fnins.2021.678978</pub-id><pub-id pub-id-type="pmcid">PMC8280316</pub-id><pub-id pub-id-type="pmid">34276289</pub-id></mixed-citation></ref><ref id="pone.0316262.ref089"><label>89</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Mion</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Villevieille</surname><given-names>T</given-names></name>. <article-title>Ketamine Pharmacology: An Update (Pharmacodynamics and Molecular Aspects, Recent Findings).</article-title><source>CNS Neurosci Ther.</source><year>2013</year><month>Jun</month><day>1</day>;<volume>19</volume>(<issue>6</issue>):<fpage>370</fpage>&#8211;<lpage>80</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1111/cns.12099</pub-id><pub-id pub-id-type="pmid">23575437</pub-id><pub-id pub-id-type="pmcid">PMC6493357</pub-id></mixed-citation></ref><ref id="pone.0316262.ref090"><label>90</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Peltoniemi</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Hagelberg</surname><given-names>NM</given-names></name>, <name name-style="western"><surname>Olkkola</surname><given-names>KT</given-names></name>, <name name-style="western"><surname>Saari</surname><given-names>TI</given-names></name>. <article-title>Ketamine: A Review of Clinical Pharmacokinetics and Pharmacodynamics in Anesthesia and Pain Therapy.</article-title><source>Clin Pharmacokinet</source>. <year>2016</year><month>Sep</month>;<volume>55</volume>(<issue>9</issue>):<fpage>1059</fpage>&#8211;<lpage>77</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1007/s40262-016-0383-6</pub-id><pub-id pub-id-type="pmid">27028535</pub-id></mixed-citation></ref><ref id="pone.0316262.ref091"><label>91</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Konopacki</surname><given-names>J</given-names></name>, <name name-style="western"><surname>MacIver</surname><given-names>MB</given-names></name>, <name name-style="western"><surname>Bland</surname><given-names>BH</given-names></name>, <name name-style="western"><surname>Roth</surname><given-names>SH</given-names></name>. <article-title>Carbachol-induced EEG &#8220;theta&#8221; activity in hippocampal brain slices.</article-title><source>Brain Res</source>. <year>1987</year><month>Mar</month><day>3</day>;<volume>405</volume>(<issue>1</issue>):<fpage>196</fpage>&#8211;<lpage>8</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/0006-8993(87)91009-2</pub-id><pub-id pub-id-type="pmid">3567594</pub-id></mixed-citation></ref><ref id="pone.0316262.ref092"><label>92</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Konopacki</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Go&#322;ebiewski</surname><given-names>H</given-names></name>. <article-title>Theta-like activity in hippocampal formation slices: cholinergic-GABAergic interaction</article-title>. <source>Neuroreport</source>. <year>1993</year><month>Jul</month>;<volume>4</volume>(<issue>7</issue>):<fpage>963</fpage>&#8211;<lpage>6</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1097/00001756-199307000-00032</pub-id><pub-id pub-id-type="pmid">8369490</pub-id></mixed-citation></ref><ref id="pone.0316262.ref093"><label>93</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Fellous</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Sejnowski</surname><given-names>TJ</given-names></name>. <article-title>Cholinergic induction of oscillations in the hippocampal slice in the slow (0.5&#8211;2 Hz), theta (5&#8211;12 Hz), and gamma (35&#8211;70 Hz) bands.</article-title><source>Hippocampus.</source><year>2000</year>;<volume>10</volume>(<issue>2</issue>):<fpage>187</fpage>&#8211;<lpage>97</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/(SICI)1098-1063(2000)10:2&amp;#x00026;lt;187::AID-HIPO8&amp;#x00026;gt;3.0.CO;2-M</pub-id><pub-id pub-id-type="pmid">10791841</pub-id></mixed-citation></ref><ref id="pone.0316262.ref094"><label>94</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Drexler</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Seeger</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Worek</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Thiermann</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Antkowiak</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Grasshoff</surname><given-names>C</given-names></name>. <article-title>Impact of soman and acetylcholine on the effects of propofol in cultured cortical networks</article-title>. <source>Toxicol Lett</source>. <year>2020</year><month>Apr</month><day>1</day>;<volume>322</volume>:<fpage>98</fpage>&#8211;<lpage>103</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.toxlet.2020.01.012</pub-id><pub-id pub-id-type="pmid">31954869</pub-id></mixed-citation></ref><ref id="pone.0316262.ref095"><label>95</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Cole</surname><given-names>AE</given-names></name>, <name name-style="western"><surname>Nicoll</surname><given-names>RA</given-names></name>. <article-title>Acetylcholine mediates a slow synaptic potential in hippocampal pyramidal cells</article-title>. <source>Science</source>. <year>1983</year><month>Sep</month><day>23</day>;<volume>221</volume>(<issue>4617</issue>):<fpage>1299</fpage>&#8211;<lpage>301</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1126/science.6612345</pub-id><pub-id pub-id-type="pmid">6612345</pub-id></mixed-citation></ref><ref id="pone.0316262.ref096"><label>96</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Marrosu</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Portas</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Mascia</surname><given-names>MS</given-names></name>, <name name-style="western"><surname>Casu</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>F&#224;</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Giagheddu</surname><given-names>M</given-names></name>, <etal>et al</etal>. <article-title>Microdialysis measurement of cortical and hippocampal acetylcholine release during sleep-wake cycle in freely moving cats</article-title>. <source>Brain Res</source>. <year>1995</year><month>Feb</month><day>13</day>;<volume>671</volume>(<issue>2</issue>):<fpage>329</fpage>&#8211;<lpage>32</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/0006-8993(94)01399-3</pub-id><pub-id pub-id-type="pmid">7743225</pub-id></mixed-citation></ref><ref id="pone.0316262.ref097"><label>97</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Vanini</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Lydic</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Baghdoyan</surname><given-names>HA</given-names></name>. <article-title>GABA-to-ACh ratio in basal forebrain and cerebral cortex varies significantly during sleep</article-title>. <source>Sleep</source>. <year>2012</year><month>Oct</month><day>1</day>;<volume>35</volume>(<issue>10</issue>):<fpage>1325</fpage>&#8211;<lpage>34</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.5665/sleep.2106</pub-id><pub-id pub-id-type="pmid">23024430</pub-id><pub-id pub-id-type="pmcid">PMC3443758</pub-id></mixed-citation></ref><ref id="pone.0316262.ref098"><label>98</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Yao</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>van Velthoven</surname><given-names>CTJ</given-names></name>, <name name-style="western"><surname>Kunst</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>M</given-names></name>, <name name-style="western"><surname>McMillen</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>C</given-names></name>, <etal>et al</etal>. <article-title>A high-resolution transcriptomic and spatial atlas of cell types in the whole mouse brain</article-title>. <source>Nature</source>. <year>2023</year><month>Dec</month><day>13</day>;<volume>624</volume>(<issue>7991</issue>):<fpage>317</fpage>&#8211;<lpage>32</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/s41586-023-06812-z</pub-id><pub-id pub-id-type="pmid">38092916</pub-id><pub-id pub-id-type="pmcid">PMC10719114</pub-id></mixed-citation></ref><ref id="pone.0316262.ref099"><label>99</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Struys</surname><given-names>MM</given-names></name>, <name name-style="western"><surname>De Smet</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Depoorter</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Versichelen</surname><given-names>LF</given-names></name>, <name name-style="western"><surname>Mortier</surname><given-names>EP</given-names></name>, <name name-style="western"><surname>Dumortier</surname><given-names>FJ</given-names></name>, <etal>et al</etal>. <article-title>Comparison of plasma compartment versus two methods for effect compartment&#8212;controlled target-controlled infusion for propofol</article-title>. <source>Anesthesiology</source>. <year>2000</year><month>Feb</month>;<volume>92</volume>(<issue>2</issue>):<fpage>399</fpage>&#8211;<lpage>406</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1097/00000542-200002000-00021</pub-id><pub-id pub-id-type="pmid">10691226</pub-id></mixed-citation></ref><ref id="pone.0316262.ref100"><label>100</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Hijazi</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Boulieu</surname><given-names>R</given-names></name>. <article-title>Protein binding of ketamine and its active metabolites to human serum</article-title>. <source>Eur J Clin Pharmacol</source>. <year>2002</year><month>Apr</month>;<volume>58</volume>(<issue>1</issue>):<fpage>37</fpage>&#8211;<lpage>40</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1007/s00228-002-0439-4</pub-id><pub-id pub-id-type="pmid">11956671</pub-id></mixed-citation></ref><ref id="pone.0316262.ref101"><label>101</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Dayton</surname><given-names>PG</given-names></name>, <name name-style="western"><surname>Stiller</surname><given-names>RL</given-names></name>, <name name-style="western"><surname>Cook</surname><given-names>DR</given-names></name>, <name name-style="western"><surname>Perel</surname><given-names>JM</given-names></name>. <article-title>The binding of ketamine to plasma proteins: Emphasis on human plasma</article-title>. <source>Eur J Clin Pharmacol</source>. <year>1983</year><month>Nov</month>;<volume>24</volume>(<issue>6</issue>):<fpage>825</fpage>&#8211;<lpage>31</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1007/BF00607095</pub-id><pub-id pub-id-type="pmid">6884418</pub-id></mixed-citation></ref><ref id="pone.0316262.ref102"><label>102</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Ishii-Maruhama</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Higuchi</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Nakanou</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Honda-Wakasugi</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Yabuki-Kawase</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Maeda</surname><given-names>S</given-names></name>, <etal>et al</etal>. <article-title>In vitro changes in the proportion of protein-unbound-free propofol induced by valproate.</article-title><source>J Anesth.</source><year>2018</year><source>Oct</source>;<volume>32</volume>(<issue>5</issue>):<fpage>688</fpage>&#8211;<lpage>93</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1007/s00540-018-2540-6</pub-id><pub-id pub-id-type="pmid">30062394</pub-id></mixed-citation></ref><ref id="pone.0316262.ref103"><label>103</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Franks</surname><given-names>NP</given-names></name>, <name name-style="western"><surname>Lieb</surname><given-names>WR</given-names></name>. <article-title>Molecular and cellular mechanisms of general anaesthesia</article-title>. <source>Nature</source>. <year>1994</year><month>Feb</month><day>17</day>;<volume>367</volume>(<issue>6464</issue>):<fpage>607</fpage>&#8211;<lpage>14</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/367607a0</pub-id><pub-id pub-id-type="pmid">7509043</pub-id></mixed-citation></ref><ref id="pone.0316262.ref104"><label>104</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Schnoebel</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Wolff</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Peters</surname><given-names>SC</given-names></name>, <name name-style="western"><surname>Br&#228;u</surname><given-names>ME</given-names></name>, <name name-style="western"><surname>Scholz</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Hempelmann</surname><given-names>G</given-names></name>, <etal>et al</etal>. <article-title>Ketamine impairs excitability in superficial dorsal horn neurones by blocking sodium and voltage-gated potassium currents</article-title>. <source>Br J Pharmacol</source>. <year>2005</year><month>Nov</month>;<volume>146</volume>(<issue>6</issue>):<fpage>826</fpage>&#8211;<lpage>33</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/sj.bjp.0706385</pub-id><pub-id pub-id-type="pmid">16151436</pub-id><pub-id pub-id-type="pmcid">PMC1751212</pub-id></mixed-citation></ref><ref id="pone.0316262.ref105"><label>105</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Zanos</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Moaddel</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Morris</surname><given-names>PJ</given-names></name>, <name name-style="western"><surname>Georgiou</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Fischell</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Elmer</surname><given-names>GI</given-names></name>, <etal>et al</etal>. <article-title>NMDAR inhibition-independent antidepressant actions of ketamine metabolites</article-title>. <source>Nature</source>. <year>2016</year><month>May</month><day>26</day>;<volume>533</volume>(<issue>7604</issue>):<fpage>481</fpage>&#8211;<lpage>6</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/nature17998</pub-id><pub-id pub-id-type="pmid">27144355</pub-id><pub-id pub-id-type="pmcid">PMC4922311</pub-id></mixed-citation></ref><ref id="pone.0316262.ref106"><label>106</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Levin-Arama</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Abraham</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Waner</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Harmelin</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Steinberg</surname><given-names>DM</given-names></name>, <name name-style="western"><surname>Lahav</surname><given-names>T</given-names></name>, <etal>et al</etal>. <article-title>Subcutaneous Compared with Intraperitoneal KetamineXylazine for Anesthesia of Mice</article-title>. <source>J Am Assoc Lab Anim Sci</source>. <year>2016</year><month>Nov</month>;<volume>55</volume>(<issue>6</issue>):<fpage>794</fpage>&#8211;<lpage>800</lpage>. <pub-id pub-id-type="pmid">27931319</pub-id><pub-id pub-id-type="pmcid">PMC5113882</pub-id></mixed-citation></ref><ref id="pone.0316262.ref107"><label>107</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Yang</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Cui</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Sang</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Dong</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Ni</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Ma</surname><given-names>S</given-names></name>, <etal>et al</etal>. <article-title>Ketamine blocks bursting in the lateral habenula to rapidly relieve depression</article-title>. <source>Nature</source>. <year>2018</year><month>Feb</month><day>14</day>;<volume>554</volume>(<issue>7692</issue>):<fpage>317</fpage>&#8211;<lpage>22</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/nature25509</pub-id><pub-id pub-id-type="pmid">29446381</pub-id></mixed-citation></ref><ref id="pone.0316262.ref108"><label>108</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Cichon</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Wasilczuk</surname><given-names>AZ</given-names></name>, <name name-style="western"><surname>Looger</surname><given-names>LL</given-names></name>, <name name-style="western"><surname>Contreras</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Kelz</surname><given-names>MB</given-names></name>, <name name-style="western"><surname>Proekt</surname><given-names>A</given-names></name>. <article-title>Ketamine triggers a switch in excitatory neuronal activity across neocortex</article-title>. <source>Nat Neurosci</source>. <year>2022</year><month>Nov</month><day>24</day>;<volume>26</volume>(<issue>1</issue>):<fpage>39</fpage>&#8211;<lpage>52</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/s41593-022-01203-5</pub-id><pub-id pub-id-type="pmid">36424433</pub-id><pub-id pub-id-type="pmcid">PMC10823523</pub-id></mixed-citation></ref><ref id="pone.0316262.ref109"><label>109</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Ribeiro</surname><given-names>PO</given-names></name>, <name name-style="western"><surname>Tom&#233;</surname><given-names>AR</given-names></name>, <name name-style="western"><surname>Silva</surname><given-names>HB</given-names></name>, <name name-style="western"><surname>Cunha</surname><given-names>RA</given-names></name>, <name name-style="western"><surname>Antunes</surname><given-names>LM</given-names></name>. <article-title>Clinically relevant concentrations of ketamine mainly affect long-term potentiation rather than basal excitatory synaptic transmission and do not change paired-pulse facilitation in mouse hippocampal slices</article-title>. <source>Brain Res</source>. <year>2014</year><month>Apr</month><day>29</day>;<volume>1560</volume>:<fpage>10</fpage>&#8211;<lpage>7</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.brainres.2014.03.004</pub-id><pub-id pub-id-type="pmid">24637258</pub-id></mixed-citation></ref><ref id="pone.0316262.ref110"><label>110</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Idvall</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Ahlgren</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Aronsen</surname><given-names>KR</given-names></name>, <name name-style="western"><surname>Stenberg</surname><given-names>P</given-names></name>. <article-title>Ketamine infusions: pharmacokinetics and clinical effects</article-title>. <source>Br J Anaesth</source>. <year>1979</year><month>Dec</month>;<volume>51</volume>(<issue>12</issue>):<fpage>1167</fpage>&#8211;<lpage>73</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/bja/51.12.1167</pub-id><pub-id pub-id-type="pmid">526385</pub-id></mixed-citation></ref><ref id="pone.0316262.ref111"><label>111</label><mixed-citation publication-type="journal"><name name-style="western"><surname>van Aerde</surname><given-names>KI</given-names></name>, <name name-style="western"><surname>Feldmeyer</surname><given-names>D</given-names></name>. <article-title>Morphological and physiological characterization of pyramidal neuron subtypes in rat medial prefrontal cortex</article-title>. <source>Cereb Cortex</source>. <year>2015</year><month>Mar</month>;<volume>25</volume>(<issue>3</issue>):<fpage>788</fpage>&#8211;<lpage>805</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/cercor/bht278</pub-id><pub-id pub-id-type="pmid">24108807</pub-id></mixed-citation></ref><ref id="pone.0316262.ref112"><label>112</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Farnes</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Juel</surname><given-names>BE</given-names></name>, <name name-style="western"><surname>Nilsen</surname><given-names>AS</given-names></name>, <name name-style="western"><surname>Romundstad</surname><given-names>LG</given-names></name>, <name name-style="western"><surname>Storm</surname><given-names>JF</given-names></name>. <article-title>Increased signal diversity/complexity of spontaneous EEG, but not evoked EEG responses, in ketamine-induced psychedelic state in humans.</article-title><source>PLoS One.</source><year>2020</year><month>Nov</month><day>23</day>;<volume>15</volume>(<issue>11</issue>):<fpage>e0242056</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1371/journal.pone.0242056</pub-id><pub-id pub-id-type="pmid">33226992</pub-id><pub-id pub-id-type="pmcid">PMC7682856</pub-id></mixed-citation></ref><ref id="pone.0316262.ref113"><label>113</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Arena</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Juel</surname><given-names>BE</given-names></name>, <name name-style="western"><surname>Comolatti</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Thon</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Storm</surname><given-names>JF</given-names></name>. <article-title>Capacity for consciousness under ketamine anaesthesia is selectively associated with activity in posteromedial cortex in rats.</article-title><source>Neurosci Conscious. 2022</source><month>Mar</month><day>4</day>;<year>2022</year>(<issue>1</issue>):niac004. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/nc/niac004</pub-id><pub-id pub-id-type="pmid">35261778</pub-id><pub-id pub-id-type="pmcid">PMC8896332</pub-id></mixed-citation></ref><ref id="pone.0316262.ref114"><label>114</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Moghaddam</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Adams</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Verma</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Daly</surname><given-names>D</given-names></name>. <article-title>Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex</article-title>. <source>J Neurosci</source>. <year>1997</year><month>Apr</month><day>15</day>;<volume>17</volume>(<issue>8</issue>):<fpage>2921</fpage>&#8211;<lpage>7</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1523/JNEUROSCI.17-08-02921.1997</pub-id><pub-id pub-id-type="pmid">9092613</pub-id><pub-id pub-id-type="pmcid">PMC6573099</pub-id></mixed-citation></ref><ref id="pone.0316262.ref115"><label>115</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Smith</surname><given-names>C</given-names></name>, <name name-style="western"><surname>McEwan</surname><given-names>AI</given-names></name>, <name name-style="western"><surname>Jhaveri</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Wilkinson</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Goodman</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Smith</surname><given-names>LR</given-names></name>, <etal>et al</etal>. <article-title>The interaction of fentanyl on the Cp50 of propofol for loss of consciousness and skin incision</article-title>. <source>Anesthesiology</source>. <year>1994</year><month>Oct</month>;<volume>81</volume>(<issue>4</issue>):<fpage>820</fpage>&#8211;<lpage>8</lpage>; discussion 26A. <pub-id pub-id-type="pmid">7943832</pub-id></mixed-citation></ref><ref id="pone.0316262.ref116"><label>116</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Braathen</surname><given-names>MR</given-names></name>, <name name-style="western"><surname>Rimstad</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Dybvik</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Nyg&#229;rd</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Raeder</surname><given-names>J</given-names></name>. <article-title>Online exhaled propofol monitoring in normal-weight and obese surgical patients.</article-title><source>Acta Anaesthesiol Scand.</source><year>2022</year><month>May</month>;<volume>66</volume>(<issue>5</issue>):<fpage>598</fpage>&#8211;<lpage>605</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1111/aas.14043</pub-id><pub-id pub-id-type="pmid">35138633</pub-id><pub-id pub-id-type="pmcid">PMC9305953</pub-id></mixed-citation></ref><ref id="pone.0316262.ref117"><label>117</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Cockshott</surname><given-names>ID</given-names></name>, <name name-style="western"><surname>Douglas</surname><given-names>EJ</given-names></name>, <name name-style="western"><surname>Plummer</surname><given-names>GF</given-names></name>, <name name-style="western"><surname>Simons</surname><given-names>PJ</given-names></name>. <article-title>The pharmacokinetics of propofol in laboratory animals</article-title>. <source>Xenobiotica</source>. <year>1992</year><month>Mar</month>;<volume>22</volume>(<issue>3</issue>):<fpage>369</fpage>&#8211;<lpage>75</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.3109/00498259209046648</pub-id><pub-id pub-id-type="pmid">1496826</pub-id></mixed-citation></ref><ref id="pone.0316262.ref118"><label>118</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Leist</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Ghallab</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Graepel</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Marchan</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Hassan</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Bennekou</surname><given-names>SH</given-names></name>, <etal>et al</etal>. <article-title>Adverse outcome pathways: opportunities, limitations and open questions</article-title>. <source>Arch Toxicol</source>. <year>2017</year><month>Nov</month>;<volume>91</volume>(<issue>11</issue>):<fpage>3477</fpage>&#8211;<lpage>505</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1007/s00204-017-2045-3</pub-id><pub-id pub-id-type="pmid">29051992</pub-id></mixed-citation></ref><ref id="pone.0316262.ref119"><label>119</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Hengstler</surname><given-names>JG</given-names></name>, <name name-style="western"><surname>Sj&#246;gren</surname><given-names>AK</given-names></name>, <name name-style="western"><surname>Zink</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Hornberg</surname><given-names>JJ</given-names></name>. <article-title>In vitro prediction of organ toxicity: the challenges of scaling and secondary mechanisms of toxicity</article-title>. <source>Arch Toxicol</source>. <year>2020</year><month>Feb</month>;<volume>94</volume>(<issue>2</issue>):<fpage>353</fpage>&#8211;<lpage>6</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1007/s00204-020-02669-7</pub-id><pub-id pub-id-type="pmid">32067068</pub-id><pub-id pub-id-type="pmcid">PMC8211595</pub-id></mixed-citation></ref><ref id="pone.0316262.ref120"><label>120</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Storm</surname><given-names>JF</given-names></name>, <name name-style="western"><surname>Klink</surname><given-names>PC</given-names></name>, <name name-style="western"><surname>Aru</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Senn</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Goebel</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Pigorini</surname><given-names>A</given-names></name>, <etal>et al</etal>. <article-title>An integrative, multiscale view on neural theories of consciousness</article-title>. <source>Neuron</source>. <year>2024</year><month>May</month><day>15</day>;<volume>112</volume>(<issue>10</issue>):<fpage>1531</fpage>&#8211;<lpage>52</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.neuron.2024.02.004</pub-id><pub-id pub-id-type="pmid">38447578</pub-id></mixed-citation></ref></ref-list></back></article></pmc-articleset>